https://www.openhealthgroup.com/insights/ 2026-09-21T19:05:05+00:00 https://www.openhealthgroup.com/insights/clinical-economic-and-humanistic-burden-of-needlestick-injuries-in-healthcare-workers/ 2018-03-02T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-2.png https://www.openhealthgroup.com/insights/effective-antimicrobial-stewardship-strategies-for-cost-effective-utilization-of-telavancin-for-the-treatment-of-patients-with-hospital-acquired-bacterial-pneumonia-caused-by-staphylococcus-aureus/ 2018-03-02T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bacteria.jpeg https://www.openhealthgroup.com/insights/systematic-review-and-benchmarking-of-quality-adjusted-time-without-symptoms-or-toxicity-q-twist-in-oncology/ 2018-03-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Witte-bloedcellen-415x276-adjusted-v2.png https://www.openhealthgroup.com/insights/humanistic-burden-of-disease-for-patients-with-advanced-melanoma-in-canada/ 2018-03-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/8.jpeg https://www.openhealthgroup.com/insights/estimating-the-global-prevalence-of-transthyretin-familial-amyloid-polyneuropathy/ 2018-03-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nrv2_415x276.png https://www.openhealthgroup.com/insights/palivizumab-in-the-prevention-of-severe-respiratory-syncytial-virus-infection-in-children-with-congenital-heart-disease-a-novel-cost-utility-modeling-study-reflecting-evidence-based-clinical-pathways/ 2018-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Respiratory.jpeg https://www.openhealthgroup.com/insights/real-world-effectiveness-of-brentuximab-vedotin-versus-physicians-choice-chemotherapy-in-patients-with-relapsed-refractory-hodgkin-lymphoma-following-autologous-stem-cell-transplantation-in-the-unit/ 2018-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Research.jpeg https://www.openhealthgroup.com/insights/biologic-treatment-sequences-for-plaque-psoriasis-a-cost-utility-analysis-based-on-10-years-of-dutch-real-world-evidence-from-biocapture/ 2018-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Dead-sea.jpeg https://www.openhealthgroup.com/insights/economic-value-of-using-partially-hydrolysed-infant-formula-for-risk-reduction-of-atopic-dermatitis-in-high-risk-infants-not-exclusively-breastfed-in-singapore/ 2018-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bottle_na3.jpeg https://www.openhealthgroup.com/insights/evaluation-and-performance-of-a-newly-developed-patient-reported-outcome-instrument-for-diarrhea-predominant-irritable-bowel-syndrome-in-a-clinical-study-population/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-reportedoutcomes.jpeg https://www.openhealthgroup.com/insights/cost-utility-of-elbasvir-grazoprevir-in-patients-with-chronic-hepatitis-c-genotype-1-infection/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis-C_2022-08-23-124034_ulmo.png https://www.openhealthgroup.com/insights/brentuximab-vedotin-in-patients-with-relapsed-or-refractory-hodgkin-lymphoma-who-are-ineligible-for-autologous-stem-cell-transplant-a-germany-and-united-kingdom-retrospective-study/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lymphoma.jpeg https://www.openhealthgroup.com/insights/drug-survival-of-second-biological-dmard-therapy-in-patients-with-rheumatoid-arthritis-a-retrospective-non-interventional-cohort-analysis/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cohort-analysis.jpeg https://www.openhealthgroup.com/insights/non-persistence-and-non-adherence-to-mtx-therapy-in-patients-with-rheumatoid-arthritis-a-retrospective-cohort-study-based-on-german-ra-patients/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/medication-equipment-and-supply-costs-for-common-interventions-providing-extended-post-surgical-analgesia-following-total-knee-arthroplasty-in-us-hospitals/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Surgery-II.jpeg https://www.openhealthgroup.com/insights/clinical-and-economic-analysis-of-outcomes-of-dose-tapering-or-withdrawal-of-tumor-necrosis-factor-ce-b1-inhibitors-upon-achieving-stable-disease-activity-in-rheumatoid-arthritis-patients/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-e1523544978656.jpeg https://www.openhealthgroup.com/insights/direct-medical-costs-of-treatment-in-newly-diagnosed-high-grade-glioma-among-commercially-insured-us-patients/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Neurology-e1523531680765.jpeg https://www.openhealthgroup.com/insights/the-cost-of-oropharyngeal-cancer-in-england-a-retrospective-hospital-data-analysis/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/biologic-disease-modifying-antirheumatic-drugs-in-a-national-privately-insured-population-utilization-expenditures-and-price-trends/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/economic-evaluations_2022-08-11-081427_hlsh.png https://www.openhealthgroup.com/insights/epidemiology-and-outcome-of-invasive-fungal-infections-and-methicillin-resistant-staphylococcus-aureus-mrsa-pneumonia-and-complicated-skin-and-soft-tissue-infections-cssti-in-lebanon-and-saudi-ara/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus3.png https://www.openhealthgroup.com/insights/the-importance-of-economic-perspective-and-quantitative-approaches-in-oncology-value-frameworks-of-drug-selection-and-shared-decision-making/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-06-29-133423_xmqf.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-rivaroxaban-for-treatment-and-secondary-prevention-of-venous-thromboembolism-in-the-netherlands/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-08-10-104945_ebnb.png https://www.openhealthgroup.com/insights/psychometric-evaluation-of-the-chinese-breast-cancer-prevention-trial-symptom-scale/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/b-cancer.png https://www.openhealthgroup.com/insights/capsaicin-8-patch-versus-oral-neuropathic-pain-medications-for-the-treatment-of-painful-diabetic-peripheral-neuropathy-a-systematic-literature-review-and-network-meta-analysis/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain_2022-08-10-172011_rybm.png https://www.openhealthgroup.com/insights/quality-adjusted-survival-with-combination-nal-iri5-fu-lv-vs-5-fu-lv-alone-in-metastatic-pancreatic-cancer-patients-previously-treated-with-gemcitabine-based-therapy-a-q-twist-analysis/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic_2022-07-01-105030_jlgn.png https://www.openhealthgroup.com/insights/qualitative-modification-and-development-of-patient-and-caregiver-reported-outcome-measures-for-iron-chelation-therapy/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-shaking-hand-e1523542406321.jpeg https://www.openhealthgroup.com/insights/headroom-beyond-the-quality-adjusted-life-year-the-case-of-complex-pediatric-neurology/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pediatric-neurology.png https://www.openhealthgroup.com/insights/treatment-patterns-resource-utilization-and-outcomes-among-hospitalized-patients-with-methicillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-in-lebanon-and-saudi-ara/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-laboratory-e1523881881966.jpeg https://www.openhealthgroup.com/insights/budget-impact-of-perampanel-as-adjunctive-treatment-of-uncontrolled-partial-onset-and-primary-generalized-tonic-clonic-seizures-in-the-united-states/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan.png https://www.openhealthgroup.com/insights/disease-burden-of-systemic-light-chain-amyloidosis-a-systematic-literature-review/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/amyloidosis.png https://www.openhealthgroup.com/insights/budgetary-impact-of-cabazitaxel-use-after-docetaxel-treatment-for-metastatic-castration-resistant-prostate-cancer/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer_2022-08-16-123235_xadz.png https://www.openhealthgroup.com/insights/optimizing-choice-of-oral-interferon-free-treatment-for-genotype-1-hepatitis-c-virus-using-testing-for-ns5a-resistance-a-cost-utility-analysis-from-the-perspective-of-the-italian-national-health-serv/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis.png https://www.openhealthgroup.com/insights/burden-of-methicillin-resistant-staphylococcus-aureus-pneumonia-among-hospitalized-patients-in-lebanon-and-saudi-arabia/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus-aureus_2022-08-10-172350_uwbb.png https://www.openhealthgroup.com/insights/burden-and-treatment-patterns-of-invasive-fungal-infections-in-hospitalized-patients-in-the-middle-east-real-world-data-from-saudi-arabia-and-lebanon/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/fungal-infections.png https://www.openhealthgroup.com/insights/making-economic-evaluations-more-helpful-for-treatment-choices-in-haemophilia/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood_2022-07-11-134110_uqzx.png https://www.openhealthgroup.com/insights/measuring-the-benefits-of-healthcare-dalys-and-qalys-does-the-choice-of-measure-matter-a-case-study-of-two-preventive-interventions/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_588071354_2022-07-11-132011_rjxv.jpg https://www.openhealthgroup.com/insights/mapping-to-estimate-health-state-utility-from-non-preference-based-outcome-measures-an-ispor-good-practices-for-outcomes-research-task-force-report/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-07-11-133439_bxkz.png https://www.openhealthgroup.com/insights/dosing-patterns-and-medication-adherence-in-bipolar-disorder-patients-treated-with-lurasidone-a-us-retrospective-claims-database-analysis/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor.png https://www.openhealthgroup.com/insights/peripheral-nerve-blocks-in-the-management-of-postoperative-pain-challenges-and-opportunities/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Nerve.png https://www.openhealthgroup.com/insights/analysis-of-treatment-patterns-and-persistence-on-branded-and-generic-medications-in-major-depressive-disorder-using-retrospective-claims-data/ 2018-03-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/older-adult_2022-08-11-085818_ytyv.png https://www.openhealthgroup.com/insights/systematic-review-treatment-pattern-and-clinical-effectiveness-and-safety-of-pharmaceutical-therapies-for-crohns-disease-in-europe/ 2018-04-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Figuur-1.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective/ 2018-04-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus-aureus.png https://www.openhealthgroup.com/insights/risk-of-skeletal-related-events-among-elderly-prostate-cancer-patients-by-site-of-metastasis-at-diagnosis/ 2018-04-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer_2022-06-30-111251_tsjq.png https://www.openhealthgroup.com/insights/risk-of-skeletal-related-events-among-elderly-prostate-cancer-patients-by-site-of-metastasis-at-diagnosis-copy/ 2018-04-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_551260165_2022-07-01-122343_gdzb.jpg https://www.openhealthgroup.com/insights/risk-of-skeletal-related-events-among-elderly-prostate-cancer-patients-by-site-of-metastasis-at-diagnosis-copy-2/ 2018-04-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-myeloma.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy/ 2018-04-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye_2022-08-09-133658_aggx.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy/ 2018-04-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Instrument-development-e1523542084829.jpeg https://www.openhealthgroup.com/insights/economic-analysis-of-empiric-versus-diagnostic-driven-strategies-for-immunocompromised-patients-with-suspected-fungal-infections-in-the-peoples-republic-of-china/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/fungal-infection.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-c-4/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/older-adult.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-c-5/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bladder_2022-08-10-113942_cxdn.png https://www.openhealthgroup.com/insights/patient-reported-outcomes-in-head-and-neck-and-thyroid-cancer-randomised-controlled-trials-a-systematic-review-of-completeness-of-reporting-and-impact-on-interpretation/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/34729101_s.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-cop/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes1.png https://www.openhealthgroup.com/insights/impact-of-pulmonary-exacerbations-and-lung-function-on-generic-health-related-quality-of-life-in-patients-with-cystic-fibrosis/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/QoL-fibrosis.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-c-6/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-c-8/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart2_2022-08-16-125928_bkej.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-11/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-1-6/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_433526728_2022-06-30-111808_ucer.jpg https://www.openhealthgroup.com/insights/bleeding-related-complications-and-readmission-rates-associated-with-fibrin-sealant-use-in-patients-undergoing-coronary-artery-bypass-graft-surgery-in-the-united-states/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Surgery-II.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-1-5/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/8.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-1-8/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_2022-07-13-115038_qjyn.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-1-9/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-08-09-143601_czou.png https://www.openhealthgroup.com/insights/patient-and-physician-preferences-for-oral-pharmacotherapy-for-overactive-bladder-two-discrete-choice-experiments/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bladder-e1523540306971.jpeg https://www.openhealthgroup.com/insights/economic-and-humanistic-burden-of-dry-eye-disease-in-europe-north-america-and-asia-a-systematic-literature-review/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye_pic1.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-1-3/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/schizophrenia_2022-08-10-105954_fszv.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-c-9/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bowel-red.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-14/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bladder.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-12/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus-aureus.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-13/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/economic-evaluations_2022-08-11-084553_lsjd.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-15/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes4.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-16/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-19/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bacteria-163711.jpg https://www.openhealthgroup.com/insights/using-health-economic-models-to-help-guide-healthcare-decisions/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-06-27-122903_ejun.png https://www.openhealthgroup.com/insights/associations-between-signs-and-symptoms-of-dry-eye-disease-a-systematic-review/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye_pic1.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-20/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer_2022-07-12-062355_tkhy.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-2-2/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication-Antibiotic.png https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-2-3/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-Methicillin-resistant-e1523545410333.jpeg https://www.openhealthgroup.com/insights/pathophysiology-and-burden-of-infection-in-patients-with-diabetes-mellitus-and-peripheral-vascular-disease-focus-on-skin-and-soft-tissue-infections/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Publication-Diabetes.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-2-5/ 2018-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-e1523544978656.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-2-7/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-arthritis_2022-07-05-132514_rcdc.png https://www.openhealthgroup.com/insights/burden-of-dose-escalation-with-tumour-necrosis-factor-inhibitors-in-rheumatoid-arthritis-a-systematic-review-of-frequency-and-costs/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Research.jpeg https://www.openhealthgroup.com/insights/survival-quality-adjusted-survival-and-other-clinical-end-points-in-older-advanced-non-small-cell-lung-cancer-patients-treated-with-albumin-bound-paclitaxel/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication-survival.jpeg https://www.openhealthgroup.com/insights/early-switch-early-discharge-opportunities-for-hospitalized-patients-with-methicillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-proof-of-concept-in-the-united-arab-e/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication-Staphylococcus-e1523544590407.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-2-6/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1892973439_2022-08-09-160721_fkvc.jpg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-22/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Neurology-e1523531680765.jpeg https://www.openhealthgroup.com/insights/nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-treated-with-linezolid-or-vancomycin-a-secondary-economic-analysis-of-resource-use-from-a-spanish-perspective-copy-copy-2-23/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Opioid-publication-e1523531398670.jpeg https://www.openhealthgroup.com/insights/economic-value-of-atopic-dermatitis-prevention-via-infant-formula-use-in-high-risk-malaysian-infants/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infant-formula-e1523531157391.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-partially-hydrolyzed-whey-protein-formula-in-the-primary-prevention-of-atopic-dermatitis-in-high-risk-urban-infants-in-southeast-asia/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Dead-sea.jpeg https://www.openhealthgroup.com/insights/economic-burden-of-atopic-dermatitis-in-high-risk-infants-receiving-cows-milk-or-partially-hydrolyzed-100-whey-based-formula/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bottle_na3.jpeg https://www.openhealthgroup.com/insights/front-line-dose-escalated-immunochemotherapy-is-associated-with-a-significant-progression-free-survival-advantage-in-patients-with-double-hit-lymphomas-a-systematic-review-and-meta-analysis/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lymphoma.jpeg https://www.openhealthgroup.com/insights/a-cost-utility-analysis-of-simeprevir-used-with-peginterferon-e2-80-89-e2-80-89ribavirin-in-the-management-of-genotype-1-hepatitis-c-virus-infection-from-the-perspective-of-the-uk-national-health-se/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/3.jpeg https://www.openhealthgroup.com/insights/which-factors-enhance-positive-drug-reimbursement-recommendation-in-scotland-a-retrospective-analysis-2006-2013/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Scotland-e1523520852731.jpeg https://www.openhealthgroup.com/insights/a-simulation-study-of-sample-size-demonstrated-the-importance-of-the-number-of-events-per-variable-to-develop-prediction-models-in-clustered-data/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Modeling-e1523879599422.jpeg https://www.openhealthgroup.com/insights/the-cost-effectiveness-of-dapagliflozin-versus-sulfonylurea-as-an-add-on-to-metformin-in-the-treatment-of-type-2-diabetes-mellitus/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717_2022-06-29-142129_lsic.jpg https://www.openhealthgroup.com/insights/surgical-vs-nonsurgical-treatment-of-adults-with-displaced-fractures-of-the-proximal-humerus-the-profher-randomized-clinical-trial/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Surgery-e1523519903862.jpeg https://www.openhealthgroup.com/insights/addressing-innovative-off-label-medication-use-at-an-academic-medical-center/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-2.png https://www.openhealthgroup.com/insights/health-economic-comparison-of-slit-allergen-and-scit-allergoid-immunotherapy-in-patients-with-seasonal-grass-allergic-rhinoconjunctivitis-in-germany/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Grass-allergic-rhinoconjunctivitis.jpeg https://www.openhealthgroup.com/insights/the-role-of-clinical-decision-support-in-pharmacist-response-to-drug-interaction-alerts/ 2018-04-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pharmacy-e1523518362484.jpeg https://www.openhealthgroup.com/insights/measurement-of-adherence-to-bcr-abl-inhibitor-therapy-in-chronic-myeloid-leukemia-current-situation-and-future-challenges/ 2018-04-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-treatment-duration-between-studies.jpeg https://www.openhealthgroup.com/insights/investigating-the-evidence-of-the-real-life-impact-of-acute-hyperglycaemia/ 2018-04-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_210913_065814.jpeg https://www.openhealthgroup.com/insights/clinical-effectiveness-of-liraglutide-in-type-2-diabetes-treatment-in-the-real-world-setting-a-systematic-literature-review/ 2018-04-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication.jpeg https://www.openhealthgroup.com/insights/clinical-effectiveness-of-liraglutide-in-type-2-diabetes-treatment-in-the-real-world-setting-a-systematic-literature-review/ 2018-04-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication.jpeg https://www.openhealthgroup.com/insights/antibiotic-treatment-patterns-across-europe-in-patients-with-complicated-skin-and-soft-tissue-infections-due-to-meticillin-resistant-staphylococcus-aureus-a-plea-for-implementation-of-early-switch-an/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/3.jpeg https://www.openhealthgroup.com/insights/the-burden-and-management-of-fxiii-deficiency/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Neuropathy-e1523465210386.jpeg https://www.openhealthgroup.com/insights/a-global-overview-of-the-impact-of-peritoneal-dialysis-first-or-favored-policies-an-opinion/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/health-economic-evaluation-of-patients-treated-for-nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus-secondary-analysis-of-a-multicenter-randomized-clinical-trial-of-vancomyc/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/8.jpeg https://www.openhealthgroup.com/insights/cost-of-opioid-intravenous-patient-controlled-analgesia-results-from-a-hospital-database-analysis-and-literature-assessment/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-2.png https://www.openhealthgroup.com/insights/qualitative-development-of-a-patient-reported-outcome-symptom-measure-in-diarrhea-predominant-irritable-bowel-syndrome/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/rising-inequalities-in-income-and-health-in-china-who-is-left-behind/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/China-e1523540686656.jpeg https://www.openhealthgroup.com/insights/assessing-uncertainties-surrounding-combined-endpoints-for-use-in-economic-models/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Modeling-e1523879599422.jpeg https://www.openhealthgroup.com/insights/the-impact-of-parenteral-nutrition-preparation-on-bloodstream-infection-risk-and-costs/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bacteria.jpeg https://www.openhealthgroup.com/insights/economic-evaluation-of-primary-prevention-of-cardiovascular-diseases-in-mild-hypertension-a-scenario-analysis-for-the-netherlands/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Stethoscoop.jpeg https://www.openhealthgroup.com/insights/exacerbation-related-impairment-of-quality-of-life-and-work-productivity-in-severe-and-very-severe-chronic-obstructive-pulmonary-disease/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Respiratory.jpeg https://www.openhealthgroup.com/insights/eliciting-health-state-utilities-for-dupuytrens-contracture-using-a-discrete-choice-experiment/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/3d.jpeg https://www.openhealthgroup.com/insights/cost-of-treatment-in-a-us-commercially-insured-hiv-1-infected-population/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-laboratory-e1523881881966.jpeg https://www.openhealthgroup.com/insights/systematic-review-and-meta-analysis-of-pharmacological-therapies-for-pain-associated-with-postherpetic-neuralgia-and-less-common-neuropathic-conditions/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nrv2_415x276.png https://www.openhealthgroup.com/insights/burden-of-nonnucleoside-reverse-transcriptase-inhibitor-resistance-in-hiv-1-infected-patients-a-systematic-review-and-meta-analysis/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Modeling-e1523879599422.jpeg https://www.openhealthgroup.com/insights/economic-burden-of-inpatient-and-outpatient-antibiotic-treatment-for-methicillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-a-comparison-of-linezolid-vancomycin-and/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/4a.jpeg https://www.openhealthgroup.com/insights/the-prevalence-of-transmitted-resistance-to-first-generation-non-nucleoside-reverse-transcriptase-inhibitors-and-its-potential-economic-impact-in-hiv-infected-patients/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/5e.jpeg https://www.openhealthgroup.com/insights/association-between-drug-tolerability-and-medical-resource-use-in-prophylaxis-of-invasive-fungal-infections-after-allogeneic-hematopoietic-stem-cell-transplant/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stem-cell-transplant.png https://www.openhealthgroup.com/insights/the-cost-effectiveness-of-paliperidone-extended-release-in-spain/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-06-29-141806_tipv.png https://www.openhealthgroup.com/insights/denosumab-versus-zoledronic-acid-for-treatment-of-bone-metastases-in-men-with-castration-resistant-prostate-cancer-a-cost-effectiveness-analysis/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer_2022-08-09-125714_jwou.png https://www.openhealthgroup.com/insights/impact-of-adverse-events-on-costs-and-quality-of-life-in-protease-inhibitor-based-combination-therapy-for-hepatitis-c/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis-C.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-3-year-vs-1-year-adjuvant-therapy-with-imatinib-in-patients-with-high-risk-of-gastrointestinal-stromal-tumour-recurrence-in-the-netherlands-a-modelling-study-alongside-the-ssgxv/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bowel_2022-08-09-153303_tmte.png https://www.openhealthgroup.com/insights/clinical-economic-and-humanistic-burdens-of-skeletal-related-events-associated-with-bone-metastases/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/skeletal_2022-08-10-121201_gkrk.png https://www.openhealthgroup.com/insights/systematic-review-and-comparison-of-pharmacologic-therapies-for-neuropathic-pain-associated-with-spinal-cord-injury/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/6a.jpeg https://www.openhealthgroup.com/insights/indirect-costs-associated-with-metastatic-breast-cancer/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer_2022-07-12-062355_tkhy.png https://www.openhealthgroup.com/insights/health-economic-review-of-zoledronic-acid-for-the-management-of-skeletal-related-events-in-bone-metastatic-prostate-cancer/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer_2022-07-12-071025_sgmk.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-immunotherapy-in-patients-with-grass-pollen-allergic-rhinoconjunctivitis-in-germany/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-17.png https://www.openhealthgroup.com/insights/fingolimod-reduces-direct-medical-costs-compared-to-natalizumab-in-patients-with-relapsing-remitting-multiple-sclerosis-in-the-netherlands/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-sclerosis_2022-08-22-102243_rymj.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-denosumab-versus-zoledronic-acid-in-the-management-of-skeletal-metastases-secondary-to-breast-cancer/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer_2022-08-09-135327_suww.png https://www.openhealthgroup.com/insights/clinical-and-economic-burden-of-extra-articular-manifestations-in-ankylosing-spondylitis-patients-treated-with-anti-tumor-necrosis-factor-agents/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_33256001311_2022-08-10-122550_xfgv.jpg https://www.openhealthgroup.com/insights/estimating-preference-based-eq-5d-health-state-utilities-or-item-responses-from-neuropathic-pain-scores/ 2018-04-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neuropathic.png https://www.openhealthgroup.com/insights/estimating-the-quality-of-life-impact-and-cost-effectiveness-of-alpha-blocker-and-anti-muscarinic-combination-treatment-in-men-with-lower-urinary-tract-symptoms-related-to-benign-prostatic-hyperplasia/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/urinary-tract.png https://www.openhealthgroup.com/insights/mapping-of-the-insomnia-severity-index-and-other-sleep-measures-to-euroqol-eq-5d-health-state-utilities/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/7a.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-zoledronic-acid-in-the-management-of-skeletal-metastases-in-patients-with-lung-cancer-in-france-germany-portugal-the-netherlands-and-the-united-kingdom/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungcancer.jpg https://www.openhealthgroup.com/insights/pharmacoeconomics-of-bisphosphonates-for-skeletal-related-event-prevention-in-metastatic-non-breast-solid-tumours/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/skeletal.png https://www.openhealthgroup.com/insights/clinical-and-economic-burden-of-clostridium-difficile-infection-in-europe-a-systematic-review-of-healthcare-facility-acquired-infection/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_433526728_2022-08-10-123328_tsvs.jpg https://www.openhealthgroup.com/insights/the-burden-of-atrial-fibrillation-in-the-netherlands/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ventricular-fibrillation.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-zoledronic-acid-in-the-management-of-skeletal-metastases-in-hormone-refractory-prostate-cancer-patients-in-france-germany-portugal-and-the-netherlands/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/skeletal_2022-08-10-110426_ebdb.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-atazanavir-ritonavir-compared-with-lopinavir-ritonavir-in-treatment-naive-human-immunodeficiency-virus-1-patients-in-sweden/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.png https://www.openhealthgroup.com/insights/indirect-comparisons-of-second-generation-tyrosine-kinase-inhibitors-in-cml-case-study-using-baseline-population-characteristics/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/yrosine-kinase-inhibitors.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-zoledronic-acid-in-the-prevention-of-skeletal-related-events-in-patients-with-bone-metastases-secondary-to-advanced-renal-cell-carcinoma-application-to-france-germany-and-the/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Renal-cell-carcinoma.png https://www.openhealthgroup.com/insights/us-hospital-database-analysis-of-invasive-aspergillosis-in-the-chronic-obstructive-pulmonary-disease-non-traditional-host/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart_2022-08-16-125713_rshj.png https://www.openhealthgroup.com/insights/economic-evaluation-of-zoledronic-acid-for-the-prevention-of-osteoporotic-fractures-in-postmenopausal-women-with-early-stage-breast-cancer-receiving-aromatase-inhibitors-in-the-uk/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer_2022-08-09-104923_zyfi.png https://www.openhealthgroup.com/insights/health-economics-of-insomnia-therapy-implications-for-policy/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1106545970_2022-07-12-071615_qvvr.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-eszopiclone-for-the-treatment-of-adults-with-primary-chronic-insomnia/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-08-09-134333_ewsi.png https://www.openhealthgroup.com/insights/transmission-dynamic-model-to-capture-the-indirect-effects-of-infant-vaccination-with-prevnar-7-valent-pneumococcal-conjugate-vaccine-pcv7-in-older-populations/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717_2022-06-29-120547_sfvj.jpg https://www.openhealthgroup.com/insights/efficacy-of-recombinant-activated-factor-vii-vs-activated-prothrombin-complex-concentrate-for-patients-suffering-from-haemophilia-complicated-with-inhibitors-a-bayesian-meta-regression/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-cells_2022-07-14-105033_belr.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-long-acting-risperidone-in-sweden/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717_2022-08-10-111622_xstc.jpg https://www.openhealthgroup.com/insights/costs-and-consequences-of-clopidogrel-versus-aspirin-for-secondary-prevention-of-ischaemic-events-in-high-risk-atherosclerotic-patients-in-sweden-a-lifetime-model-based-on-the-caprie-trial-and-high/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-08-09-132119_qdyp.png https://www.openhealthgroup.com/insights/increasing-decision-makers-access-to-economic-evaluations-alternative-methods-of-communicating-the-information/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/economic-evaluations.png https://www.openhealthgroup.com/insights/a-pharmacoeconomic-analysis-of-compliance-gains-on-antipsychotic-medications/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pillss.png https://www.openhealthgroup.com/insights/a-pharmaco-economic-analysis-of-patients-with-schizophrenia-switching-to-generic-risperidone-involving-a-possible-compliance-loss/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/8.jpeg https://www.openhealthgroup.com/insights/modelling-approaches-the-case-of-schizophrenia/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/schizophrenia.png https://www.openhealthgroup.com/insights/the-cost-effectiveness-of-atypicals-in-the-uk/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-06-29-142611_ajjf.png https://www.openhealthgroup.com/insights/a-review-of-the-clinical-and-economic-outcomes-of-imatinib-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-1.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-and-budget-impact-of-long-acting-risperidone-in-portugal-a-modeling-exercise/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-08-09-155543_ovpz.png https://www.openhealthgroup.com/insights/oral-antiplatelet-therapy-in-secondary-prevention-of-cardiovascular-events-an-assessment-from-the-payers-perspective/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Stethoscoop.jpeg https://www.openhealthgroup.com/insights/long-term-clopidogrel-therapy-in-patients-receiving-percutaneous-coronary-intervention/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Surgery-II.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-adalimumab-for-the-treatment-of-ankylosing-spondylitis-in-the-united-kingdom/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ankylosing-spondylitis.png https://www.openhealthgroup.com/insights/health-economic-review-of-recombinant-activated-factor-vii-for-treatment-of-bleeding-episodes-in-hemophilia-patients-with-inhibitors/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-laboratory-e1523881881966.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-long-term-treatment-with-eszopiclone-for-primary-insomnia-in-adults-a-decision-analytical-model/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1106545970_2022-08-10-111352_xeni.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-clopidogrel-vs-aspirin-treatment-in-high-risk-acute-coronary-syndrome-patients-in-denmark/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Stethoscoop.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-bisphosphonates-in-the-management-of-breast-cancer-patients-with-bone-metastases/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Research.jpeg https://www.openhealthgroup.com/insights/prevalence-and-incidence-of-severe-sepsis-in-dutch-intensive-care-units/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/modelling-the-treated-course-of-schizophrenia-development-of-a-discrete-event-simulation-model/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Modeling-e1523879599422.jpeg https://www.openhealthgroup.com/insights/the-use-of-a-surgical-sealant-coseal-in-cardiac-and-vascular-reconstructive-surgery-an-economic-analysis/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Surgery-II.jpeg https://www.openhealthgroup.com/insights/economic-impact-of-antidiabetic-medications-and-glycemic-control-on-managed-care-organizations-a-review-of-the-literature/ 2018-04-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_210913_065814.jpeg https://www.openhealthgroup.com/insights/review-of-economic-value-drivers-of-the-treatment-of-overactive-bladder/ 2018-06-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/real-world-outcomes-of-multiple-myeloma-retrospective-analysis-of-the-czech-registry-of-monoclonal-gammopathies/ 2018-06-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MultipleMyeloma.jpeg https://www.openhealthgroup.com/insights/performance-status-dynamics-during-treatment-with-nab-paclitaxel-plus-gemcitabine-versus-gemcitabine-alone-for-metastatic-pancreatic-cancer/ 2018-06-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-Publication-Performance-Status-Fig3.jpeg https://www.openhealthgroup.com/insights/nab-paclitaxel-plus-gemcitabine-in-metastatic-pancreatic-adenocarcinoma-australian-subset-analyses-of-the-phase-iii-mpact-trial/ 2018-06-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/3.jpeg https://www.openhealthgroup.com/insights/quality-adjusted-outcomes-stratified-by-response-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-first-line-nab-paclitaxel-carboplatin-or-paclitaxel-carboplatin/ 2018-06-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication-Quality-adjusted-Outcomes-e1530267042734.png https://www.openhealthgroup.com/insights/patient-reported-treatment-related-symptom-burden-for-patients-with-advanced-melanoma-in-canada/ 2018-06-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Instrument-development-e1523542084829.jpeg https://www.openhealthgroup.com/insights/quality-adjusted-survival-with-nab-paclitaxel-versus-standard-paclitaxel-in-metastatic-breast-cancer-a-q-twist-analysis/ 2018-06-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-publication-Q-Twist-e1530268952732.png https://www.openhealthgroup.com/insights/development-of-a-comprehensive-dataset-of-hepatitis-c-patients-and-examination-of-disease-epidemiology-in-the-united-states-2013-2016/ 2018-07-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-laboratory-e1523881881966.jpeg https://www.openhealthgroup.com/insights/cardiovascular-hazards-of-insufficient-treatment-of-depression-among-patients-with-known-cardiovascular-disease-a-propensity-score-adjusted-analysis-bangalore-et-al-cvd-hazards-of-insufficient-depr/ 2018-07-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/21816457_s-e1532087649288.jpeg https://www.openhealthgroup.com/insights/a-new-method-for-valuing-health-directly-eliciting-personal-utility-functions/ 2018-07-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-centricopy.jpeg https://www.openhealthgroup.com/insights/cost-analysis-for-different-sequential-treatment-regimens-for-metastatic-renal-cell-carcinoma-in-china/ 2018-08-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lymphoma.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-voriconazole-fluconazole-and-amphotericin-b-for-invasive-fungal-infections-following-allogeneic-hematopoietic-stem-cell-transplantation-in-mexico/ 2018-09-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Morfin-Otero-2018_CE-model-prophylaxis-therapies-IFI-002-1.jpeg https://www.openhealthgroup.com/insights/psychosocial-correlates-of-continuous-glucose-monitoring-use-in-youth-and-adults-with-type-1-diabetes-and-parents-of-youth/ 2018-09-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glucose.png https://www.openhealthgroup.com/insights/psychosocial-impact-of-real-time-continuous-glucose-monitoring-cgm-in-type-1-diabetes-t1d/ 2018-09-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glucose.jpeg https://www.openhealthgroup.com/insights/treatment-patterns-and-healthcare-resource-utilization-among-patients-with-hereditary-angioedema-in-the-united-states/ 2018-10-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/13023_2018_922_Fig1_HTML.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-alemtuzumab-in-the-treatment-of-relapsing-forms-of-multiple-sclerosis-in-the-united-states/ 2018-12-14T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/1-s2.0-S109830151836145X-gr2.gif https://www.openhealthgroup.com/insights/pulmonary-embolism-in-europe-burden-of-illness-in-relationship-to-healthcare-resource-utilization-and-return-to-work/ 2019-01-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pulmonary-Embolism-Small.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-teriflunomide-compared-to-interferon-beta-1b-for-relapsing-multiple-sclerosis-patients-in-china/ 2019-01-28T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pic-Pub-1.png https://www.openhealthgroup.com/insights/impact-of-medical-marijuana-legalization-on-opioid-use-chronic-opioid-use-and-high-risk-opioid-use/ 2019-01-28T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills-6729830_1280.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-standalone-trabecular-micro-bypass-stents-in-patients-with-mild-to-moderate-open-angle-glaucoma-in-canada/ 2019-01-28T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Instrument-development-e1523542084829.jpeg https://www.openhealthgroup.com/insights/health-state-utilities-for-acute-myeloid-leukaemia-a-time-trade-off-study/ 2019-02-04T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Descriptive-statistics-for-health-state-utilities-in-AML.jpeg https://www.openhealthgroup.com/insights/co-creation-of-patient-engagement-quality-guidance-for-medicines-development-an-international-multistakeholder-initiative/ 2019-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bmjinnov-2018-000317-F1.large_.jpeg https://www.openhealthgroup.com/insights/patient-centered-outcomes-in-participants-of-a-buprenorphine-monthly-depot-bup-xr-double-blind-placebo-controlled-multicenter-phase-3-study/ 2019-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PROimage.jpeg https://www.openhealthgroup.com/insights/real-world-use-of-extracorporeal-photopheresis-for-patients-with-cutaneous-t-cell-lymphoma-in-the-united-states-2010-2015/ 2019-03-25T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-Lymphoma-scaled-e1583849962849.jpeg https://www.openhealthgroup.com/insights/overall-survival-costs-and-healthcare-resource-use-by-line-of-therapy-in-medicare-patients-with-newly-diagnosed-metastatic-urothelial-carcinoma/ 2019-03-25T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lymphoma.jpeg https://www.openhealthgroup.com/insights/health-related-quality-of-life-and-mortality-in-patients-with-pulmonary-embolism-a-prospective-cohort-study-in-seven-european-countries/ 2019-04-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Table-3-pulmonary.png https://www.openhealthgroup.com/insights/literature-review-and-economic-evaluation-of-oral-and-intramuscular-ziprasidone-treatment-among-patients-with-schizophrenia-in-china/ 2019-05-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pharmacy.jpg https://www.openhealthgroup.com/insights/treatment-of-immunocompromised-patients-with-suspected-invasive-fungal-infections-economic-analysis-of-diagnostic-driven-versus-empirical-strategies-in-algeria-and-egypt/ 2019-05-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/InvasiveFungalInfections.jpeg https://www.openhealthgroup.com/insights/lost-annual-productivity-costs-due-to-uterine-cancer-deaths-in-the-united-states-in-2014/ 2019-05-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/uterine.jpeg https://www.openhealthgroup.com/insights/early-switch-early-discharge-opportunities-for-hospitalized-patients-with-methicillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-in-brazil/ 2019-05-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus-aureus.png https://www.openhealthgroup.com/insights/budget-impact-of-netupitant-palonosetron-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting/ 2019-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemotherapy.jpeg https://www.openhealthgroup.com/insights/comparative-efficacy-and-safety-of-dolutegravir-relative-to-common-core-agents-in-treatment-naive-patients-infected-with-hiv-1-a-systematic-review-and-network-meta-analysis/ 2019-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.jpeg https://www.openhealthgroup.com/insights/comparative-efficacy-and-safety-of-dolutegravir-relative-to-common-core-agents-in-treatment-naive-patients-infected-with-hiv-1-a-systematic-review-and-network-meta-analysis/ 2019-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-early-treatment-with-originator-biologics-or-their-biosimilars-after-methotrexate-failure-in-patients-with-established-rheumatoid-arthritis/ 2019-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Research.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-a-fixed-combination-of-netupitant-and-palonosetron-nepa-relative-to-aprepitant-plus-granisetron-apr-gran-for-prophylaxis-of-chemotherapy-induced-nausea-and-vomiting-cinv/ 2019-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemo.jpeg https://www.openhealthgroup.com/insights/long-term-assessment-of-healthcare-utilization-five-years-after-respiratory-syncytial-virus-infection-in-us-infants/ 2019-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/infant.jpeg https://www.openhealthgroup.com/insights/comparison-of-quality-of-life-measurements-eq-5d-5l-versus-disease-treatment-specific-measures-in-pulmonary-embolism-and-deep-vein-thrombosis/ 2019-06-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/DVT.jpeg https://www.openhealthgroup.com/insights/uncertainty-and-cures-discontinuation-irreversibility-and-outcomes-based-payments-what-is-different-about-a-one-off-treatment/ 2019-06-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cures.jpeg https://www.openhealthgroup.com/insights/measuring-recovery-in-opioid-use-disorder-clinical-utility-and-psychometric-properties-of-the-treatment-effectiveness-assessment/ 2019-07-01T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SAR-10-13-g0001-opioid.jpeg https://www.openhealthgroup.com/insights/treatment-patterns-and-outcomes-for-patients-with-unresectable-stage-iii-and-metastatic-melanoma-in-the-usa/ 2019-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MetastaticMelanoma.jpeg https://www.openhealthgroup.com/insights/reducing-red-blood-cell-transfusion-in-orthopedic-and-cardiac-surgeries-with-antifibrinolytics-a-laboratory-medicine-best-practice-systematic-review-and-meta-analysis/ 2019-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RedBloodCells.jpeg https://www.openhealthgroup.com/insights/a-quality-adjusted-time-without-symptoms-or-toxicity-q-twist-analysis-of-nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma-arcc/ 2019-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RCC.jpeg https://www.openhealthgroup.com/insights/restrictive-transfusion-strategy-and-clinical-decision-support-practices-for-reducing-rbc-transfusion-overuse/ 2019-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717_2022-06-30-123121_yirg.jpg https://www.openhealthgroup.com/insights/patient-reported-outcomes-in-schizophrenia-patients-treated-with-once-monthly-extended-release-risperidone-in-a-long-term-clinical-study/ 2019-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Publication-Patient-Reported-Outcomes-in-Schizophrenia-e1563991333997.jpeg https://www.openhealthgroup.com/insights/new-methods-for-modelling-eq-5d-5l-value-sets-an-application-to-english-data/ 2019-08-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/EQ-5D-5L.jpeg https://www.openhealthgroup.com/insights/development-and-validation-of-a-novel-risk-stratification-algorithm-for-relapsed-multiple-myeloma/ 2019-08-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-cells.png https://www.openhealthgroup.com/insights/a-psychometric-analysis-and-revalidation-of-the-yale-brown-obsessive-compulsive-scale-modified-for-binge-eating-in-adults-with-binge-eating-disorder/ 2019-09-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Binge-eating-e1567506248565.png https://www.openhealthgroup.com/insights/systematic-review-and-network-meta-analysis-of-the-efficacy-and-safety-of-lidocaine-700-e2-80-89mg-medicated-plaster-vs-pregabalin/ 2019-09-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/DOCTOR-PRESCRIPTION-1.jpeg https://www.openhealthgroup.com/insights/economic-impact-model-of-delayed-inhibitor-development-in-patients-with-hemophilia-a-receiving-emicizumab-for-the-prevention-of-bleeding-events/ 2019-09-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/DOCTOR-PRESCRIPTION-1.jpeg https://www.openhealthgroup.com/insights/critical-appraisal-and-data-extraction-for-systematic-reviews-of-prediction-modelling-studies-the-charms-checklist/ 2019-10-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/economic-burden-associated-with-inadequate-antidepressant-medication-management-among-patients-with-depression-and-known-cardiovascular-diseases-insights-from-a-united-states-based-retrospective-clai/ 2019-11-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Stethoscoop.jpeg https://www.openhealthgroup.com/insights/treatment-characteristics-for-nonmetastatic-castration-resistant-prostate-cancer-in-the-united-states-europe-and-japan/ 2019-11-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-e1573480530433.jpeg https://www.openhealthgroup.com/insights/projected-impact-of-elbasvir-grazoprevir-in-patients-with-hepatitis-c-virus-genotype-1-and-chronic-kidney-disease-in-vietnam/ 2019-11-18T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis-c.jpeg https://www.openhealthgroup.com/insights/real-world-effectiveness-and-real-world-cost-effectiveness-of-intravitreal-aflibercept-and-intravitreal-ranibizumab-in-neovascular-age-related-macular-degeneration-systematic-review-and-meta-analysis/ 2019-11-18T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Eye-medicine.jpeg https://www.openhealthgroup.com/insights/anemia-management-and-audit-feedback-practices-for-reducing-overuse-of-rbc-transfusion-a-laboratory-medicine-best-practice-systematic-review-and-meta-analysis/ 2019-11-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MultipleMyeloma.jpeg https://www.openhealthgroup.com/insights/methodology-of-a-novel-risk-stratification-algorithm-for-patients-with-multiple-myeloma-in-the-relapsed-setting/ 2019-11-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-test.jpeg https://www.openhealthgroup.com/insights/deep-vein-thrombosis-in-europe-health-related-quality-of-life-and-mortality/ 2019-12-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pulmonary-Embolism-Article.jpeg https://www.openhealthgroup.com/insights/real-world-incidence-and-burden-of-adverse-events-among-non-metastatic-prostate-cancer-patients-treated-with-secondary-hormonal-therapies-following-androgen-deprivation-therapy/ 2019-12-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/a-targeted-literature-review-of-the-disease-burden-in-patients-with-symptomatic-peripheral-artery-disease/ 2020-01-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Artery-disease-e1578320270730.jpeg https://www.openhealthgroup.com/insights/the-impact-of-co-morbidity-on-the-disease-burden-of-vte/ 2020-01-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Thrombosis.jpeg https://www.openhealthgroup.com/insights/deep-vein-thrombosis-in-europe-burden-of-illness-in-relationship-to-healthcare-resource-utilization-and-return-to-work-2/ 2020-01-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Stethoscoop.jpeg https://www.openhealthgroup.com/insights/measurement-properties-of-commonly-used-generic-preference-based-measures-in-east-and-south-east-asia-a-systematic-review/ 2020-01-10T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Instrument-development-e1523542084829.jpeg https://www.openhealthgroup.com/insights/symptoms-of-major-depressive-disorder-scale-performance-of-a-novel-patient-reported-symptom-measure/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Neurology-e1523531680765.jpeg https://www.openhealthgroup.com/insights/development-of-an-initial-conceptual-model-of-multiple-myeloma-to-support-clinical-and-health-economics-decision-making/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Model-Meyloma.jpeg https://www.openhealthgroup.com/insights/epidemiological-and-clinical-characteristics-of-symptomatic-hereditary-transthyretin-amyloid-polyneuropathy-a-global-case-series/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Figure-Pub-Marc.jpeg https://www.openhealthgroup.com/insights/the-economic-burden-of-bronchiectasis-known-and-unknown-a-systematic-review/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Figure-Fransisco.jpeg https://www.openhealthgroup.com/insights/patient-reported-prevalence-of-metamorphopsia-and-predictors-of-vision-related-quality-of-life/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Metamorphopsia.jpeg https://www.openhealthgroup.com/insights/oral-corticosteroid-exposure-and-increased-risk-of-related-complications-in-patients-with-noninfectious-intermediate-posterior-or-panuveitis-real-world-data-analysis/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pharmacy-e1523518362484.jpeg https://www.openhealthgroup.com/insights/quality-adjusted-survival-of-nivolumab-plus-ipilimumab-or-nivolumab-alone-versus-ipilimumab-alone-among-treatment-naive-patients-with-advanced-melanoma-a-quality-adjusted-time-without-symptoms-or-tox/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Melanoma.jpeg https://www.openhealthgroup.com/insights/effects-of-monthly-buprenorphine-extended-release-injections-on-patient-centered-outcomes-a-long-term-study/ 2020-01-21T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/costs-and-cost-drivers-associated-with-non-small-cell-lung-cancer-patients-who-received-two-or-more-lines-of-therapy-in-europe/ 2020-01-23T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/iStock-1183309585-e1579782028965.jpeg https://www.openhealthgroup.com/insights/the-development-of-the-iciq-uab-a-patient-reported-outcome-measure-for-underactive-bladder/ 2020-02-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bladder-e1523540306971.jpeg https://www.openhealthgroup.com/insights/economic-outcomes-related-to-persistence-and-dosing-of-celecoxib-in-patients-with-osteoarthritis-oa-using-a-retrospective-claims-database-analysis/ 2020-02-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Osteoarthritis.jpeg https://www.openhealthgroup.com/insights/management-of-patients-with-acute-lymphoblastic-leukemia-in-routine-clinical-practice-minimal-residual-disease-testing-treatment-patterns-and-clinical-outcomes-in-belgium-greece-and-switzerland/ 2020-03-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-e1583505961954.jpeg https://www.openhealthgroup.com/insights/landscape-of-health-related-quality-of-life-in-patients-with-early-stage-pancreatic-cancer-receiving-adjuvant-or-neoadjuvant-chemotherapy-a-systematic-literature-review/ 2020-03-10T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/phosphodiesterase-type-5-inhibitor-prescription-patterns-in-the-united-states-among-men-with-erectile-dysfunction-an-update/ 2020-03-10T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/DOCTOR-PRESCRIPTION-1.jpeg https://www.openhealthgroup.com/insights/a-budget-impact-analysis-for-making-treatment-decisions-based-on-anti-cyclic-citrullinated-peptide-anti-ccp-testing-in-rheumatoid-arthritis/ 2020-03-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-e1523544978656.jpeg https://www.openhealthgroup.com/insights/recovery-from-opioid-use-disorder-oud-after-monthly-long-acting-buprenorphine-treatment-12-month-longitudinal-outcomes-from-recover-an-observational-study/ 2020-04-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_210913_065814.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-of-alternative-strategies-for-vaccination-of-adolescents-against-serogroup-b-imd-with-the-menb-fhbp-vaccine-in-canada-2/ 2020-04-05T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Approved_Vis-Abstract-scaled-1.jpeg https://www.openhealthgroup.com/insights/the-costs-of-treating-vaginal-and-vulval-cancer-in-england-2009-2015/ 2020-04-08T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HPV-1.jpeg https://www.openhealthgroup.com/insights/modified-delphi-study-of-decision-making-around-treatment-sequencing-in-relapsing-remitting-multiple-sclerosis/ 2020-04-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/iStock-919897348-e1587384332588.jpeg https://www.openhealthgroup.com/insights/early-switch-early-discharge-opportunities-for-hospitalized-patients-with-methicillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-saudi-arabia-and-united-arab-emirates/ 2020-06-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/real-world-treatment-patterns-and-outcomes-using-terlipressin-in-203-patients-with-the-hepatorenal-syndrome/ 2020-06-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Liver-disease.jpeg https://www.openhealthgroup.com/insights/real-e2-80-90world-treatment-patterns-and-outcomes-in-non-e2-80-90transplant-newly-diagnosed-multiple-myeloma-in-france-germany-italy-and-the-united-kingdom/ 2020-06-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-test.jpeg https://www.openhealthgroup.com/insights/nomogram-for-estimating-overall-survival-in-patients-with-metastatic-pancreatic-cancer/ 2020-06-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pancreatic-Cancer-2.jpeg https://www.openhealthgroup.com/insights/midwives-perspectives-of-respectful-maternity-care-during-childbirth-a-qualitative-study/ 2020-06-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Baby.jpeg https://www.openhealthgroup.com/insights/physician-preferences-for-non-metastatic-castration-resistant-prostate-cancer-treatment/ 2020-06-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Prostate-Cancer.png https://www.openhealthgroup.com/insights/anti-vascular-endothelial-growth-factor-in-neovascular-age-related-macular-degeneration-a-systematic-review-of-the-impact-of-anti-vegf-on-patient-outcomes-and-healthcare-systems/ 2020-07-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/iStock-1250212575.jpeg https://www.openhealthgroup.com/insights/epidemiologic-humanistic-and-economic-burden-of-hepatocellular-carcinoma-in-the-usa-a-systematic-literature-review/ 2020-07-20T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RCC.jpeg https://www.openhealthgroup.com/insights/a-quality-e2-80-90adjusted-survival-time-without-symptoms-or-toxicities-analysis-of-glasdegib-plus-low-e2-80-90dose-cytarabine-versus-low-e2-80-90dose-cytarabine-as-initial-therapy-for-acute-myeloid-l/ 2020-07-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia2.jpeg https://www.openhealthgroup.com/insights/patient-and-caregiver-benefit-risk-preferences-for-nonmetastatic-castration-resistant-prostate-cancer-treatment/ 2020-08-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/a-systematic-review-of-medical-costs-associated-with-heart-failure-in-the-usa-2014-2020/ 2020-08-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pharmacy-e1523518362484.jpeg https://www.openhealthgroup.com/insights/cost-minimization-analysis-of-dexmedetomidine-compared-to-other-sedatives-for-short-term-sedation-during-mechanical-ventilation-in-the-united-states/ 2020-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemotherapy.jpeg https://www.openhealthgroup.com/insights/machine-learning-for-precision-health-economics-and-outcomes-research-p-heor-conceptual-review-of-applications-and-next-steps/ 2020-09-20T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SMAimage.jpeg https://www.openhealthgroup.com/insights/cost-utility-of-all-oral-direct-acting-antiviral-regimens-for-the-treatment-of-genotype-1-chronic-hepatitis-c-virus-infected-patients-in-hong-kong/ 2020-09-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis-c.jpeg https://www.openhealthgroup.com/insights/patient-and-caregiver-preferences-for-haemophilia-a-treatments-a-discrete-choice-experiment/ 2020-09-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/medical-oncology-referral-and-systemic-therapy-of-patients-with-advanced-stage-urothelial-carcinoma/ 2020-09-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Carcinoma.jpeg https://www.openhealthgroup.com/insights/novel-risk-stratification-algorithm-for-estimating-the-risk-of-death-in-patients-with-relapsed-multiple-myeloma-external-validation-in-a-retrospective-chart-review/ 2020-10-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Hospital-e1523878949605.jpeg https://www.openhealthgroup.com/insights/validation-of-the-ankylosing-spondylitis-quality-of-life-assessment-tool-in-patients-with-non-radiographic-axial-spondyloarthritis/ 2020-11-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/DOCTOR-PRESCRIPTION-1.jpeg https://www.openhealthgroup.com/insights/health-state-utilities-of-patients-with-heart-failure-a-systematic-literature-review/ 2020-12-07T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/21816457_s.jpeg https://www.openhealthgroup.com/insights/under-use-of-hypomethylating-agents-in-patients-with-higher-risk-myelodysplastic-syndrome-in-the-united-states-a-large-population-based-analysis/ 2020-12-15T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-e1583505961954.jpeg https://www.openhealthgroup.com/insights/mortality-prediction-of-the-cha-2-ds-2-vasc-score-the-has-bled-score-and-their-combination-in-anticoagulated-patients-with-atrial-fibrillation/ 2020-12-29T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Atrial-Fibrillation.jpeg https://www.openhealthgroup.com/insights/direct-medical-costs-associated-with-treatment-nonpersistence-in-patients-with-higher-risk-myelodysplastic-syndromes-receiving-hypomethylating-agents-a-large-retrospective-cohort-analysis/ 2021-01-13T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-1.jpeg https://www.openhealthgroup.com/insights/what-did-time-tell-us-a-comparison-and-retrospective-validation-of-different-survival-extrapolation-methods-for-immuno-oncologic-therapy-in-advanced-or-metastatic-renal-cell-carcinoma/ 2021-01-18T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemotherapy.jpeg https://www.openhealthgroup.com/insights/budget-impact-analysis-of-introducing-a-non-reconstituted-hexavalent-vaccine-for-pediatric-immunization-in-the-united-kingdom/ 2021-02-09T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_210913_065814.jpeg https://www.openhealthgroup.com/insights/comparative-efficacy-safety-and-durability-of-dolutegravir-relative-to-common-core-agents-in-treatment-naive-patients-infected-with-hiv-1-an-update-on-a-systematic-review-and-network-meta-analysis/ 2021-03-08T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.jpeg https://www.openhealthgroup.com/insights/cost-effectiveness-for-kte-x19-car-t-therapy-for-adult-patients-with-relapsed-refractory-mantle-cell-lymphoma-in-the-united-states/ 2021-03-08T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-2.png https://www.openhealthgroup.com/insights/potential-public-health-impact-of-a-neisseria-meningitidis-a-b-c-w-and-y-pentavalent-vaccine-in-the-united-states/ 2021-03-08T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blood-laboratory-e1523881881966.jpeg https://www.openhealthgroup.com/insights/economic-value-of-lost-productivity-attributable-to-human-papillomavirus-cancer-mortality-in-the-united-states/ 2021-03-23T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HPV.jpeg https://www.openhealthgroup.com/insights/impact-of-reduced-human-papillomavirus-vaccination-coverage-rates-due-to-covid-19-in-the-united-states-a-model-based-analysis/ 2021-04-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Human-Papillomavirus.jpeg https://www.openhealthgroup.com/insights/a-systematic-literature-review-of-the-disease-burden-in-patients-with-recessive-dystrophic-epidermolysis-bullosa/ 2021-04-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/budget-impact-analysis-of-vericiguat-for-the-treatment-of-chronic-heart-failure-with-reduced-ejection-fraction-following-a-worsening-event/ 2021-04-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Vericiguat-Publication.jpg https://www.openhealthgroup.com/insights/impact-of-carbidopa-levodopa-enteral-suspension-on-quality-of-life-and-activities-of-daily-living-in-patients-with-advanced-parkinsons-disease-results-from-a-pooled-meta-analysis-2/ 2021-04-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/parkinsonsdiseasephysiothera_901541.jpeg https://www.openhealthgroup.com/insights/prevalence-of-transmitted-resistance-to-nonnucleoside-reverse-transcriptase-inhibitors-in-european-and-north-american-countries-over-20-years-an-updated-meta-analysis/ 2021-06-20T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.jpeg https://www.openhealthgroup.com/insights/burden-of-comorbid-anxiety-and-depression-in-patients-with-inflammatory-bowel-disease-a-systematic-literature-review/ 2021-06-20T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_HCP1.jpeg https://www.openhealthgroup.com/insights/the-impact-of-a-new-antimicrobial-stewardship-tool-ic-net-pharmacy-at-chelsea-and-westminster-hospital-nhs-foundation-trust/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/antimicrobial.jpg https://www.openhealthgroup.com/insights/real-world-tyrosine-kinase-inhibitor-treatment-pathways-monitoring-patterns-and-responses-in-patients-with-chronic-myeloid-leukaemia-in-the-united-kingdom-the-uk-target-cml-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leukaemia.png https://www.openhealthgroup.com/insights/consenting-patients-for-late-effects-of-head-and-neck-radiotherapy-an-audit-of-uk-oncology-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Radiotherapy.jpg https://www.openhealthgroup.com/insights/human-papillomavirus-in-head-and-neck-cancer-in-the-uk-a-clinician-survey-of-current-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Human-Papillomavirus_211013_181935.jpg https://www.openhealthgroup.com/insights/a-discrete-choice-experiment-to-determine-uk-patient-preference-for-attributes-of-disease-modifying-treatments-in-multiple-sclerosis/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_588071354_2022-03-10-110124_cqel.jpg https://www.openhealthgroup.com/insights/retrospective-real-world-evidence-study-to-review-the-current-treatment-pathways-for-myelofibrosis-from-across-the-united-kingdom-the-realism-uk-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic_2022-08-16-123717_wson.png https://www.openhealthgroup.com/insights/the-real-world-impact-of-adalimumab-on-quality-of-life-and-the-physical-and-psychological-effects-of-moderate-to-severe-psoriasis-a-uk-prospective-multicenter-observational-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriasis.png https://www.openhealthgroup.com/insights/diagnosis-management-and-prognosis-of-familial-hypercholesterolaemia-in-a-uk-tertiary-cardiac-centre/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart-doctor.png https://www.openhealthgroup.com/insights/defining-the-characteristics-of-chronic-hypoparathyroidism-not-adequately-controlled-on-conventional-therapy-consensus-findings-of-three-european-delphi-panels/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/thyroid.png https://www.openhealthgroup.com/insights/health-related-quality-of-life-and-productivity-activity-impairment-in-patients-with-transfusion-dependent-b-thalassaemia-in-the-uk-nhs-data-from-a-uk-multicentre-observational-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood.png https://www.openhealthgroup.com/insights/a-patient-centric-approach-to-cost-of-illness-research-a-case-example-of-patient-engagement-to-identify-the-hidden-costs-associated-with-blindness-due-to-inherited-retinal-dystrophies/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye.png https://www.openhealthgroup.com/insights/clinical-outcomes-with-fixed-duration-therapy-uk-real-world-data-compared-with-continuous-lenalidomide-and-low-dose-dexamethasone-therapy-first-trial-mm-020-for-transplant-ineligible-patients-with-new/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-myeloma_2022-08-10-121240_ulcx.png https://www.openhealthgroup.com/insights/pcn298-development-of-a-novel-conceptual-model-to-describe-the-patient-reported-impact-of-living-with-non-small-cell-lung-cancer/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/doctor-and-lungs-2.png https://www.openhealthgroup.com/insights/a-retrospective-observational-study-to-determine-baseline-characteristics-and-early-prescribing-patterns-for-patients-receiving-alirocumab-in-uk-clinical-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-thirdman-7659567_2022-08-11-100835_qxif.jpg https://www.openhealthgroup.com/insights/discussing-multiple-sclerosis-ms-progression-with-patients-experiences-of-uk-healthcare-professionals-from-the-spectrum-project/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stethoscope-gc90404892_1920_2022-03-10-110611_zyfp.jpg https://www.openhealthgroup.com/insights/health-utilities-associated-with-treatment-resistant-depression-in-uk-patients-and-their-caregivers/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mart-production-7089401.jpg https://www.openhealthgroup.com/insights/what-is-the-lifetime-cost-of-blindness-in-people-with-rpe65-mediated-inherited-retinal-dystrophy-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_593311505_2022-07-01-111745_hxaj.jpg https://www.openhealthgroup.com/insights/a-multi-centre-retrospective-study-to-describe-the-impact-on-healthcare-resource-use-and-real-world-effectiveness-of-golimumab-in-ankylosing-spondylitis-as-in-uk-clinical-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ankylosing-spondylitis.jpg https://www.openhealthgroup.com/insights/a-three-month-interim-analysis-of-treatment-satisfaction-with-fingolimod-in-patients-with-relapsing-remitting-multiple-sclerosis-in-the-uk-the-patient-reported-outcomes-with-fingolimod-in-local-experi/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/wheelchair-749985_640.jpg https://www.openhealthgroup.com/insights/work-productivity-in-her2-positive-breast-cancer-a-comparison-of-patients-across-stages-of-early-and-metastatic-disease/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancerHER2.jpg https://www.openhealthgroup.com/insights/the-use-of-real-world-data-for-nice-decision-making-a-review-of-submissions-to-three-treatment-effectiveness-evaluation-programmes-in-2015-and-2016/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/scientist.jpg https://www.openhealthgroup.com/insights/the-resource-cost-of-switching-stable-rheumatology-patients-from-an-originator-biologic-to-a-biosimilar-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/rheumatology.jpg https://www.openhealthgroup.com/insights/retrospective-analysis-of-the-burden-of-cytomegalovirus-disease-in-immunosuppressed-patients-after-haematopoietic-cell-transplantation-in-england/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cytomegalovirus-disease.jpg https://www.openhealthgroup.com/insights/a-retrospective-observational-study-of-patients-with-type-1-diabetes-with-self-reported-severe-hypoglycaemia-reveals-high-level-of-ambulance-attendance-but-low-levels-of-therapy-change-and-specialist/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/diabetes_211013_182648.jpg https://www.openhealthgroup.com/insights/interim-analysis-of-the-target-uk-study-real-world-use-of-tyrosine-kinase-inhibitors-in-uk-patients-with-chronic-myeloid-leukaemia/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukaemia.jpg https://www.openhealthgroup.com/insights/uk-clinical-experience-at-12-weeks-with-linaclotide-for-irritable-bowel-syndrome-with-constipation/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Irritable-Bowel-Syndrome.png https://www.openhealthgroup.com/insights/the-impact-of-a-new-antimicrobial-stewardship-tool-ic-net-pharmacy-at-chelsea-and-westminster-hospital-nhs-foundation-trust/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/antimicrobial.jpg https://www.openhealthgroup.com/insights/consenting-patients-for-late-effects-of-head-and-neck-radiotherapy-an-audit-of-uk-oncology-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Radiotherapy.jpg https://www.openhealthgroup.com/insights/human-papillomavirus-in-head-and-neck-cancer-in-the-uk-a-clinician-survey-of-current-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Human-Papillomavirus_211013_181935.jpg https://www.openhealthgroup.com/insights/a-discrete-choice-experiment-to-determine-uk-patient-preference-for-attributes-of-disease-modifying-treatments-in-multiple-sclerosis/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_588071354_2022-03-10-110124_cqel.jpg https://www.openhealthgroup.com/insights/retrospective-real-world-evidence-study-to-review-the-current-treatment-pathways-for-myelofibrosis-from-across-the-united-kingdom-the-realism-uk-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic_2022-08-16-123717_wson.png https://www.openhealthgroup.com/insights/the-real-world-impact-of-adalimumab-on-quality-of-life-and-the-physical-and-psychological-effects-of-moderate-to-severe-psoriasis-a-uk-prospective-multicenter-observational-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriasis.png https://www.openhealthgroup.com/insights/diagnosis-management-and-prognosis-of-familial-hypercholesterolaemia-in-a-uk-tertiary-cardiac-centre/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart-doctor.png https://www.openhealthgroup.com/insights/defining-the-characteristics-of-chronic-hypoparathyroidism-not-adequately-controlled-on-conventional-therapy-consensus-findings-of-three-european-delphi-panels/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/thyroid.png https://www.openhealthgroup.com/insights/health-related-quality-of-life-and-productivity-activity-impairment-in-patients-with-transfusion-dependent-b-thalassaemia-in-the-uk-nhs-data-from-a-uk-multicentre-observational-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood.png https://www.openhealthgroup.com/insights/a-patient-centric-approach-to-cost-of-illness-research-a-case-example-of-patient-engagement-to-identify-the-hidden-costs-associated-with-blindness-due-to-inherited-retinal-dystrophies/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye.png https://www.openhealthgroup.com/insights/clinical-outcomes-with-fixed-duration-therapy-uk-real-world-data-compared-with-continuous-lenalidomide-and-low-dose-dexamethasone-therapy-first-trial-mm-020-for-transplant-ineligible-patients-with-new/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-myeloma_2022-08-10-121240_ulcx.png https://www.openhealthgroup.com/insights/routine-management-healthcare-resource-use-and-patient-caregiver-reported-outcomes-of-patients-with-transfusion-dependent-%ce%b2-thalassaemia-in-the-united-kingdom-a-mixed-methods-observational-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-cells_2022-06-30-110408_ddvu.png https://www.openhealthgroup.com/insights/a-multicentre-uk-retrospective-observational-study-to-assess-the-effectiveness-of-insulin-glargine-300-units-ml-in-treating-people-with-type-1-diabetes-mellitus-in-routine-clinical-practice-sparta/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes1_2022-08-11-110858_vhpi.png https://www.openhealthgroup.com/insights/review-of-metastatic-colorectal-cancer-treatment-pathways-and-early-clinical-experience-of-trifluridine-tipiracil-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_639636403_2022-06-30-121801_jdwr.jpg https://www.openhealthgroup.com/insights/real-world-tyrosine-kinase-inhibitor-treatment-pathways-monitoring-patterns-and-responses-in-patients-with-chronic-myeloid-leukaemia-in-the-united-kingdom-the-uk-target-cml-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leukaemia.png https://www.openhealthgroup.com/insights/nurses-role-in-improving-outcomes-for-patients-with-severe-asthma/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Nurse.jpg https://www.openhealthgroup.com/insights/what-is-the-lifetime-cost-of-blindness-in-people-with-rpe65-mediated-inherited-retinal-dystrophy-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_593311505_2022-07-01-111745_hxaj.jpg https://www.openhealthgroup.com/insights/pcn298-development-of-a-novel-conceptual-model-to-describe-the-patient-reported-impact-of-living-with-non-small-cell-lung-cancer/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/doctor-and-lungs-2.png https://www.openhealthgroup.com/insights/a-retrospective-observational-study-to-determine-baseline-characteristics-and-early-prescribing-patterns-for-patients-receiving-alirocumab-in-uk-clinical-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-thirdman-7659567_2022-08-11-100835_qxif.jpg https://www.openhealthgroup.com/insights/health-utilities-associated-with-treatment-resistant-depression-in-uk-patients-and-their-caregivers/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mart-production-7089401.jpg https://www.openhealthgroup.com/insights/analysis-of-hospital-episode-statistics-data-to-demonstrate-the-secondary-care-treatment-pathway-and-outcomes-of-patients-with-cutaneous-t-cell-lymphoma-in-england/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/T-Cell-lymphoma.png https://www.openhealthgroup.com/insights/end-of-life-secondary-care-resource-use-and-costs-in-mycosis-fungoides-and-sezary-syndrome-an-analysis-of-hospital-episode-statistics/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-07-04-125645_sqcb.png https://www.openhealthgroup.com/insights/survivorship-in-acquired-thrombotic-thrombocytopenic-purpura-a-ttp-impacts-on-quality-of-life-qo-l-and-cognitive-functioning-in-patients-from-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain_2022-06-30-101708_fhif.png https://www.openhealthgroup.com/insights/a-real-world-study-investigating-the-resource-use-and-burden-associated-with-spinal-muscular-atrophy-sma-from-the-perspective-of-patients-and-carers-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spinal-Muscular-Atrophy.png https://www.openhealthgroup.com/insights/steroid-and-antibiotic-prescribing-rates-in-uk-patients-with-ulcerative-colitis-on-vedolizumab-vs-anti-tnf/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-06-30-105528_ibzw.png https://www.openhealthgroup.com/insights/current-perspectives-on-the-attainment-of-lipid-modification-goals-relating-to-the-use-of-statins-and-ezetimibe-for-the-prevention-of-cardiovascular-disease-in-the-united-kingdom/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lipid.png https://www.openhealthgroup.com/insights/a-benchmarking-audit-of-the-pre-diagnosis-pathway-in-patients-with-duchenne-muscular-dystrophy/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/muscular-dystrophy.png https://www.openhealthgroup.com/insights/age-75-years-and-not-choice-of-first-line-therapy-improves-overall-survival-in-transplant-ineligible-ndmm-patients-results-from-a-large-uk-real-world-dataset/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_HCP_Patient-1.jpg https://www.openhealthgroup.com/insights/inferior-clinical-outcomes-with-fixed-duration-therapy-for-transplant-ineligible-myeloma-patients-uk-real-world-datain-comparison-with-the-first-trial-mm-020/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancerHER2.jpg https://www.openhealthgroup.com/insights/the-burden-of-healthcare-resource-utilisation-in-patients-with-complicated-acute-bacterial-skin-and-skin-structure-infections-absssi-where-first-line-beta-lactam-antibiotics-were-unsuitable/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bacteria.png https://www.openhealthgroup.com/insights/the-missing-malignancies-follow-up-of-patients-with-pulmonary-carcinoid-tumours-in-the-uk-results-from-the-national-lung-net-pathway-leap-project/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cardio-surgery.jpg https://www.openhealthgroup.com/insights/the-incidence-diagnostic-pathway-and-management-of-pulmonary-carcinoid-tumours-in-the-uk-results-from-the-national-lung-net-pathway-leap-project/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungs.jpg https://www.openhealthgroup.com/insights/the-target-uk-study-real-world-evidence-of-molecular-response-to-tyrosine-kinase-inhibitors-supports-european-leukemia-net-2013-recommendations-for-the-management-of-chronic-myeloid-leukaemia/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-e1583505961954.jpeg https://www.openhealthgroup.com/insights/a-delphi-panel-in-the-uk-to-define-patients-with-chronic-hypoparathyroidism-not-adequately-controlled-on-standard-therapy/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hypoparathyroidism.png https://www.openhealthgroup.com/insights/quality-of-life-and-ability-to-work-in-patients-at-different-disease-stages-of-her2-breast-cancer/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_551260165.jpg https://www.openhealthgroup.com/insights/real-world-impact-of-rifaximin-%ce%b1-use-in-hepatic-encephalopathy-patients-with-advanced-liver-disease-or-continued-alcohol-misuse-a-post-hoc-analysis-of-the-impress-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney.png https://www.openhealthgroup.com/insights/rifaximin-%ce%b1-is-associated-with-reductions-in-emergency-department-resource-use-in-uk-patients-with-hepatic-encephalopathy-real-world-evidence-from-the-impress-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic-Encephalopathy.jpg https://www.openhealthgroup.com/insights/a-multi-centre-retrospective-study-to-describe-the-real-world-effectiveness-of-golimumab-for-treating-ankylosing-spondylitis-as-in-uk-clinical-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717.jpg https://www.openhealthgroup.com/insights/real-world-effectiveness-of-thrombopoietin-receptor-agonists-tr-as-in-the-management-of-immune-thrombocytopenia-itp-in-the-uk-results-from-a-post-hoc-analysis-of-the-trait-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stem-cells_2022-06-30-145456_ombu.png https://www.openhealthgroup.com/insights/a-retrospective-observational-study-of-people-with-type-1-diabetes-with-self-reported-severe-hypoglycaemia-reveals-high-level-of-ambulance-attendance-but-low-levels-of-therapy-change-and-specialist-in/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_2022-08-11-102340_udbt.png https://www.openhealthgroup.com/insights/long-term-effectiveness-of-tumour-necrosis-factor-%ce%b1-inhibitor-treatment-for-psoriatic-arthritis-in-the-uk-a-multicentre-retrospective-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mario-wallner-9964646_2022-07-11-140209_vtzs.jpg https://www.openhealthgroup.com/insights/uk-clinical-experience-up-to-52-weeks-with-linaclotide-for-irritable-bowel-syndrome-with-constipation/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bowel_2022-06-28-124801_tozu.png https://www.openhealthgroup.com/insights/an-assessment-of-patient-reported-outcome-pro-clinical-trial-data-reporting-specific-to-cholangiocarcinoma-cca/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_711170614.jpg https://www.openhealthgroup.com/insights/an-evaluation-of-the-current-treatment-pathways-and-associated-nhs-resource-use-for-the-management-of-uncontrolled-moderate-to-severe-atopic-dermatitis-in-secondary-care/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atopic-dermatitis.png https://www.openhealthgroup.com/insights/a-three-month-interim-analysis-of-fingolimod-treatment-adherence-for-relapsing-remitting-multiple-sclerosis-in-the-uk-the-patient-reported-outcomes-with-fingolimod-in-local-experience-profile-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vitamin-c-4939616_1920.jpg https://www.openhealthgroup.com/insights/the-use-of-medtech-innovation-briefings-mi-bs-to-encourage-implementation-of-innovative-technologies-a-review-of-published-briefings-from-2014-2018/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/med-tech.png https://www.openhealthgroup.com/insights/early-engagement-of-the-patient-voice-to-inform-patient-reported-outcome-measurement-in-global-pivotal-trial-of-cholangiocarcinoma/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_588071354.jpg https://www.openhealthgroup.com/insights/key-considerations-for-the-collection-of-patient-reported-outcome-pro-data-in-real-world-rw-studies/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-HCP-Patient-2.jpg https://www.openhealthgroup.com/insights/collecting-real-world-data-from-patients-with-type-1-diabetes-in-the-united-kingdom-to-complement-evidence-from-randomised-clinical-trials-sparta-a-multi-centred-observational-retrospective-research-s/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes3.png https://www.openhealthgroup.com/insights/glucocorticoid-management-of-adrenal-insufficiency-in-the-uk-assessment-using-real-world-data/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/injection.png https://www.openhealthgroup.com/insights/opportunities-for-antimicrobial-stewardship-in-patients-with-acute-bacterial-skin-and-skin-structure-infections-who-are-unsuitable-for-beta-lactam-antibiotics-a-multicenter-prospective-observational-s/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_433526728_2022-07-05-123714_efhr.jpg https://www.openhealthgroup.com/insights/improvement-of-psoriatic-nail-disease-in-psoriatic-arthritis-patients-treated-with-adalimumab-results-of-an-observational-cohort-up-to-36-months/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriatic-arthritis.png https://www.openhealthgroup.com/insights/the-real-world-use-of-bosutinib-in-patients-with-chronic-myeloid-leukaemia/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukaemia.jpg https://www.openhealthgroup.com/insights/cisplatin-use-in-uk-head-and-neck-cancer-management-a-clinician-survey-of-current-practice/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Head-and-Neck-Cancer.jpg https://www.openhealthgroup.com/insights/21st-century-state-of-rheumatoid-arthritis-management-in-the-uk/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-arthritis.png https://www.openhealthgroup.com/insights/the-impact-of-treating-to-target-in-patients-with-rheumatoid-arthritis-real-world-evidence-from-a-single-centre/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/arthritis2.jpg https://www.openhealthgroup.com/insights/uk-patient-preference-for-characteristics-of-disease-modifying-treatments-in-multiple-sclerosis/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Multiple-Sclerosis.jpg https://www.openhealthgroup.com/insights/resource-use-associated-with-hospitalisations-for-recurrent-clostridium-difficile-infection/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Clostridium-difficile-infection.jpg https://www.openhealthgroup.com/insights/a-retrospective-united-kingdom-uk-chart-review-of-early-vedolizumab-experience-real-world-treatment-effectiveness-and-safety-in-inflammatory-bowel-disease-revive/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_332560013_2022-03-29-085520_embo.jpg https://www.openhealthgroup.com/insights/the-rate-of-neutropenic-sepsis-ns-and-other-haematological-toxicities-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-treated-with-docetaxel-in-the-uk-nhs-reveal-ns/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-anna-shvets-3845126_2022-03-29-080118_oukx.jpg https://www.openhealthgroup.com/insights/resource-use-associated-with-the-management-of-docetaxel-related-haematological-toxicities-including-neutropenic-sepsis-ns-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-in-the-uk-nhs-reve/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/sepsis.jpg https://www.openhealthgroup.com/insights/the-impact-of-transition-to-adult-gastroenterology-services-on-health-related-quality-of-life-in-young-adult-patients-with-inflammatory-bowel-disease-ibd-the-uk-transit-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/gastroenterology.jpg https://www.openhealthgroup.com/insights/hospital-resource-use-and-cost-associated-with-first-line-anti-tnf-therapy-in-patients-with-inflammatory-bowel-disease-in-the-uk-comparison-of-subcutaneous-adalimumab-and-intravenous-infliximab-therap/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/IBD.jpg https://www.openhealthgroup.com/insights/a-patient-centric-approach-to-designing-a-mixed-methods-observational-study-involving-adolescents-with-x-linked-hypophosphatemia/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-cells_2022-07-01-121201_nftt.png https://www.openhealthgroup.com/insights/retrospective-study-of-the-management-of-psoriatic-arthritis-with-tumour-necrosis-factor-inhibitors-in-the-uk-capture-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/arthritis.jpg https://www.openhealthgroup.com/insights/the-impact-of-rifaximin-alpha-on-nhs-hospital-resource-use-in-uk-patients-with-hepatic-encephalopathy-a-retrospective-observational-study-impress/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic-Encephalopathy.jpg https://www.openhealthgroup.com/insights/the-impact-of-treat-to-target-on-1-year-real-world-outcomes-in-patients-with-rheumatoid-arthritis/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mario-wallner-9964646.jpg https://www.openhealthgroup.com/insights/the-profile-and-secondary-care-management-of-uk-patients-with-hidradenitis-suppurativa-interim-results-from-a-multicentre-observational-cross-sectional-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart.jpg https://www.openhealthgroup.com/insights/structured-transition-enhances-clinical-outcome-without-an-increase-in-healthcare-cost-in-adolescent-patients-with-ibd-the-uk-transit-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/adolescent-patients.jpg https://www.openhealthgroup.com/insights/real-world-use-of-adalimumab-in-uk-patients-with-ulcerative-colitis-an-observational-retrospective-study/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ulcerative-Colitis2.jpg https://www.openhealthgroup.com/insights/real-world-use-of-adalimumab-effects-on-corticosteroid-treatment-and-hospital-resource-utilisation-in-uk-patients-with-moderate-severe-ulcerative-colitis/ 2021-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ulcerative-colitis.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-axicabtagene-ciloleucel-versus-tisagenlecleucel-for-adult-patients-with-relapsed-or-refractory-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy-in-the-united-sta/ 2021-10-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/B-cell-lymphoma.jpg https://www.openhealthgroup.com/insights/non-small-cell-lung-cancer-symptom-assessment-questionnaire-psychometric-performance-and-regulatory-qualification-of-a-novel-patient-reported-symptom-measure/ 2021-10-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungcancer.jpg https://www.openhealthgroup.com/insights/biosimilar-pegfilgrastim-may-offer-affordable-treatment-options-for-patients-in-france-a-budget-impact-analysis-on-the-basis-of-clinical-trial-and-real-world-data/ 2021-10-04T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/doctor.jpg https://www.openhealthgroup.com/insights/an-integrated-pharmacokinetic-pharmacodynamic-pharmacoeconomic-modeling-method-to-evaluate-treatments-for-adults-with-schizophrenia/ 2021-10-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Schizophrenia.jpg https://www.openhealthgroup.com/insights/self-vs-other-child-vs-adult-an-experimental-comparison-of-valuation-perspectives-for-valuation-of-eq-5d-y-3l-health-states/ 2021-10-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/childvsadult.jpg https://www.openhealthgroup.com/insights/a-multicenter-randomized-double-blind-placebo-controlled-study-of-the-efficacy-tolerability-and-safety-of-celecoxib-oral-solution-elyxyb-in-acute-treatment-of-episodic-migraine-with-or-without-aura/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1423084877.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-vericiguat-for-the-treatment-of-chronic-heart-failure-with-reduced-ejection-fraction-following-a-worsening-heart-failure-event-from-a-us-medicare-perspective/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart2.png https://www.openhealthgroup.com/insights/lipid-management-across-europe-in-the-real-world-setting-a-rapid-evidence-review/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_33256001311.jpg https://www.openhealthgroup.com/insights/clinical-implications-and-cost-effectiveness-analysis-of-rivaroxaban-in-patients-with-coronary-artery-disease-or-peripheral-arterial-disease-in-the-netherlands/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1892973439.jpg https://www.openhealthgroup.com/insights/estimating-and-extrapolating-survival-using-a-state-transition-modeling-approach-a-practical-application-in-multiple-myeloma/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1371667118.jpg https://www.openhealthgroup.com/insights/phase-specific-and-lifetime-economic-burden-of-cervical-cancer-and-endometrial-cancer-in-a-commercially-insured-united-states-population/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_433526728.jpg https://www.openhealthgroup.com/insights/changes-in-healthcare-resource-use-and-costs-in-commercially-insured-insomnia-patients-initiating-suvorexant/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1106545970.jpg https://www.openhealthgroup.com/insights/evaluation-of-minimal-important-difference-and-responder-definition-in-the-eortc-qlq-pan26-module-for-assessing-health-related-quality-of-life-in-patients-with-surgically-resected-pancreatic-adenocarc/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_639636403.jpg https://www.openhealthgroup.com/insights/development-and-validation-of-a-visual-symptom-specific-patient-reported-outcomes-instrument-for-adults-with-cataract-iol-implants/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_593311505.jpg https://www.openhealthgroup.com/insights/short-communication-prevalence-of-transmitted-resistance-to-non-nucleoside-reverse-transcriptase-inhibitors-in-european-and-north-american-countries-over-20-years-an-updated-meta-analysis/ 2021-11-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bacteria-163711.jpg https://www.openhealthgroup.com/insights/epidemiology-and-clinical-characteristics-of-individuals-with-hepatitis-c-virus-infection-in-the-united-states-2017-2019/ 2021-11-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/virus-4835301_1920.jpg https://www.openhealthgroup.com/insights/nontuberculous-mycobacterial-lung-disease-caused-by-mycobacterium-avium-complex-disease-burden-unmet-needs-and-advances-in-treatment-developments/ 2021-11-23T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1694971432.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-a-12-month-fixed-duration-of-venetoclax-in-combination-with-obinutuzumab-versus-chemoimmunotherapy-and-other-novel-combinations-in-first-line-chronic-lymphocytic-leukemia-in-cana/ 2021-11-25T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-thirdman-7659567.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-a-12-month-fixed-duration-venetoclax-treatment-in-combination-with-obinutuzumab-in-first-line-unfit-chronic-lymphocytic-leukemia-in-the-united-states-1/ 2021-11-25T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stem-g37db10e69_1920.jpg https://www.openhealthgroup.com/insights/development-of-the-multiple-myeloma-symptom-and-impact-questionnaire-a-new-patient-reported-outcome-instrument-to-assess-symptom-and-impacts-in-patients-with-multiple-myeloma/ 2021-11-29T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cells-g8d310dd36_1920.jpg https://www.openhealthgroup.com/insights/does-biosimilar-bevacizumab-offer-affordable-treatment-options-for-cancer-patients-in-the-usa-a-budget-impact-analysis-from-us-commercial-and-medicare-payer-perspectives/ 2021-11-29T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/medical-g6f75532de_1920.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-intravenous-vedolizumab-vs-subcutaneous-adalimumab-for-moderately-to-severely-active-ulcerative-colitis/ 2021-12-02T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/syringe-gacec906ac_1920.jpg https://www.openhealthgroup.com/insights/an-innovative-approach-to-modelling-the-optimal-treatment-sequence-for-patients-with-relapsing-remitting-multiple-sclerosis-implementation-validation-and-impact-of-the-decision-making-approach/ 2021-12-03T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-sclerosis1_2022-08-22-101306_aqbh.png https://www.openhealthgroup.com/insights/emergency-medicine-physicians-perspectives-on-diagnostic-accuracy-in-neurology-a-qualitative-study/ 2021-12-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stethoscope-gc90404892_1920.jpg https://www.openhealthgroup.com/insights/how-is-real-world-data-currently-used-by-industry-professionals/ 2022-01-09T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lab-scaled.jpg https://www.openhealthgroup.com/insights/health-related-quality-of-life-burden-associated-with-treatment-resistant-depression-in-uk-patients-quantitative-results-from-a-mixed-methods-non-interventional-study/ 2022-01-10T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-1787622-copy-scaled.jpg https://www.openhealthgroup.com/insights/indirect-treatment-comparison-of-solriamfetol-modafinil-and-armodafinil-for-excessive-daytime-sleepiness-in-obstructive-sleep-apnea/ 2022-01-10T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/headache-gf3c3715a5_1280.jpg https://www.openhealthgroup.com/insights/phase-specific-and-lifetime-costs-of-multiple-myeloma-among-older-adults-in-the-us/ 2022-01-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-ga7b2bb89e_640.jpg https://www.openhealthgroup.com/insights/the-online-elicitation-of-personal-utility-functions-opuf-tool-a-new-method-for-valuing-health-states/ 2022-01-17T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/medical-563427_1920.jpg https://www.openhealthgroup.com/insights/fabry-disease-patient-reported-outcome-fd-pro-demonstrates-robust-measurement-properties-for-assessing-symptom-severity-in-fabry-disease/ 2022-01-18T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-HCP-Patient-2.jpg https://www.openhealthgroup.com/insights/results-from-a-cross-sectional-observational-study-to-assess-inadequate-pain-relief-in-patients-with-knee-and-or-hip-osteoarthritis-in-mexico/ 2022-01-18T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/knee-1406964_1920.jpg https://www.openhealthgroup.com/insights/clinical-and-economic-burden-of-out-of-hospital-cardiac-arrest-in-us-commercial-insurance-population-2014-to-2019/ 2022-01-26T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_417318127.jpg https://www.openhealthgroup.com/insights/exacerbations-among-chronic-bronchitis-patients-treated-with-maintenance-medications-from-a-us-managed-care-population-an-administrative-claims-data-analysis/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/doctor-and-lungs.png https://www.openhealthgroup.com/insights/healthcare-utilization-and-costs-among-chronic-bronchitis-patients-treated-with-maintenance-medications-from-a-us-managed-care-population/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_711170614_2022-03-11-122907_rvks.jpg https://www.openhealthgroup.com/insights/payers-views-on-the-heterogeneity-of-treatment-effect-in-oncology/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/oncology.png https://www.openhealthgroup.com/insights/bow-tie-optimal-pathway-discovery-analysis-of-sepsis-hospital-admissions-using-the-hospital-episode-statistics-database-in-england/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-anna-shvets-3845126.jpg https://www.openhealthgroup.com/insights/cost-efficiency-of-canagliflozin-versus-sitagliptin-for-type-2-diabetes-mellitus/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes1.png https://www.openhealthgroup.com/insights/a-retrospective-cohort-study-comparing-clinical-outcomes-and-healthcare-resource-utilisation-in-patients-undergoing-surgery-for-osteomyelitis-in-england-a-case-for-reorganising-orthopaedic-infection-2/ 2022-03-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_332560013_2022-03-11-133219_zrrb.jpg https://www.openhealthgroup.com/insights/impact-of-infliximab-dyyb-infliximab-biosimilar-on-clinical-and-patient-reported-outcomes-1-year-follow-up-results-from-an-observational-real-world-study-among-patients-with-inflammatory-bowel-disease/ 2022-03-17T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/inflamed-bowel.png https://www.openhealthgroup.com/insights/treatment-patterns-of-anti-vascular-endothelial-growth-factor-and-laser-therapy-among-patients-with-diabetic-macular-edema/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/macular-edema.png https://www.openhealthgroup.com/insights/the-cost-of-anal-cancer-in-england-retrospective-hospital-data-analysis-and-markov-model/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_711170614_2022-03-22-125938_ejns.jpg https://www.openhealthgroup.com/insights/patterns-of-clinical-management-of-atopic-dermatitis-in-infants-and-toddlers-a-survey-of-three-physician-specialties-in-the-united-states/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/people-3120717_640.jpg https://www.openhealthgroup.com/insights/comparison-of-disease-severity-measures-within-severe-and-very-severe-copd-patients-results-from-a-nationally-representative-chart-review-and-patient-survey/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing.png https://www.openhealthgroup.com/insights/direct-healthcare-resource-utilization-health-related-quality-of-life-and-work-productivity-in-patients-with-moderate-rheumatoid-arthritis-an-observational-study/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mario-wallner-9964646_2022-03-22-135422_qjqq.jpg https://www.openhealthgroup.com/insights/economic-burden-of-fatigue-or-morning-stiffness-among-patients-with-rheumatoid-arthritis-a-retrospective-analysis-from-real-world-data/ 2022-03-22T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/sore.png https://www.openhealthgroup.com/insights/evolution-of-facial-aesthetic-treatment-over-five-or-more-years-a-retrospective-cross-sectional-analysis-of-continuous-onabotulinumtoxina-treatment/ 2022-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1679689717_2022-03-28-135305_jmta.jpg https://www.openhealthgroup.com/insights/burden-of-irritable-bowel-syndrome-in-an-increasingly-cost-aware-national-health-service/ 2022-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bowel.png https://www.openhealthgroup.com/insights/claims-data-analysis-of-dosing-and-cost-of-tnf-antagonist/ 2022-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-03-28-141549_xxxu.png https://www.openhealthgroup.com/insights/the-real-world-lifetime-economic-burden-of-urothelial-carcinoma-by-stage-at-diagnosis/ 2022-03-27T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_588071354_2022-03-28-142356_fsne.jpg https://www.openhealthgroup.com/insights/survival-costs-and-health-care-resource-use-by-line-of-therapy-in-us-medicare-patients-with-newly-diagnosed-glioblastoma-a-retrospective-observational-study/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glioblastoma.png https://www.openhealthgroup.com/insights/overall-survival-costs-and-healthcare-resource-use-by-number-of-regimens-received-in-elderly-patients-with-newly-diagnosed-metastatic-triple-negative-breast-cancer/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer.png https://www.openhealthgroup.com/insights/continuation-of-systemic-treatments-and-outcomes-for-patients-with-chronic-graft-versus-host-disease-in-the-usa/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatic.png https://www.openhealthgroup.com/insights/real-world-treatment-patterns-and-outcomes-in-non-transplant-newly-diagnosed-multiple-myeloma-in-france-germany-italy-and-the-united-kingdom/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myeloma.png https://www.openhealthgroup.com/insights/healthcare-resource-use-and-cost-associated-with-timing-of-pharmacological-treatment-for-major-depressive-disorder-in-the-united-states-a-real-world-study/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/depressive-disorder.png https://www.openhealthgroup.com/insights/influence-of-real-world-characteristics-on-outcomes-for-patients-with-methicillin-resistant-staphylococcal-skin-and-soft-tissue-infections-a-multi-country-medical-chart-review-in-europe/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MEdical-chart-review.png https://www.openhealthgroup.com/insights/effect-of-treating-erectile-dysfunction-on-anagement-of-systolic-hypertension/ 2022-03-28T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hypertension.png https://www.openhealthgroup.com/insights/cost-burden-of-endothelial-keratoplasty-in-fuchs-endothelial-dystrophy-real-world-analysis-of-a-commercially-insured-us-population-2014-2019/ 2022-04-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-04-12-142104_wcfp.png https://www.openhealthgroup.com/insights/interim-scoring-for-the-eq-5d-5l-mapping-the-eq-5d-5l-to-eq-5d-3l-value-sets/ 2022-04-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-2023-06-05T112339.373.png https://www.openhealthgroup.com/insights/assessing-the-value-of-orphan-drugs-using-conventional-cost-effectiveness-analysis-is-it-fit-for-purpose/ 2022-05-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/orphan-drugs.png https://www.openhealthgroup.com/insights/patient-preferences-for-benefits-risks-and-administration-route-of-hypomethylating-agents-in-myelodysplastic-syndromes/ 2022-05-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1621031059-1-1_200423_133518.jpg https://www.openhealthgroup.com/insights/the-economic-and-clinical-burden-of-early-versus-late-initiation-of-celecoxib-among-patients-with-osteoarthritis/ 2022-05-22T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/knee-1406964_1920.jpg https://www.openhealthgroup.com/insights/long-term-changes-in-the-distributions-of-larval-and-adult-fish-in-the-northeast-u-s-shelf-ecosystem/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/das-sasha-VuBzplNNi0k-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/economic-burden-trajectories-in-commercially-insured-us-infants-with-respiratory-syncytial-virus-infection/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/baby_2022-05-31-103056_ytuk.jpg https://www.openhealthgroup.com/insights/a-pharmacoeconomic-assessment-of-recombinant-tissue-plasminogen-activator-therapy-for-acute-ischemic-stroke-in-a-tertiary-hospital-in-china/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stroke.png https://www.openhealthgroup.com/insights/treatment-free-interval-as-an-additional-measure-of-efficacy-in-a-large-uk-dataset-of-transplant-ineligible-myeloma-patients/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myeloma.png https://www.openhealthgroup.com/insights/a-study-of-national-health-service-management-of-chronic-osteoarthritis-and-low-back-pain/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/back-pain.png https://www.openhealthgroup.com/insights/consultant-input-in-acute-medical-admissions-and-patient-outcomes-in-hospitals-in-england-a-multivariate-analysis/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-HCP-1-scaled.jpg https://www.openhealthgroup.com/insights/relapsed-multiple-myeloma-in-the-uk-prior-to-the-introduction-of-novel-agents-a-response-to-koleva-et-al-2010/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myeloma2.png https://www.openhealthgroup.com/insights/economic-evaluation-of-treatment-for-mrsa-complicated-skin-and-soft-tissue-infections-in-glasgow-hospitals/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MRSA.png https://www.openhealthgroup.com/insights/treatment-pathways-and-resource-use-associated-with-recurrent-hodgkin-lymphoma-after-autologous-stem-cell-transplantation/ 2022-05-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stem-cells.png https://www.openhealthgroup.com/insights/a-literature-review-to-understand-the-burden-of-disease-in-people-living-with-tumour-induced-osteomalacia/ 2022-05-31T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Wheelchair.png https://www.openhealthgroup.com/insights/a-qualitative-study-to-understand-the-experience-of-somatostatin-analog-treatments-from-the-perspective-of-patients-with-neuroendocrine-tumors/ 2022-06-06T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neuroendocrine-tumors.png https://www.openhealthgroup.com/insights/do-subsidized-nursing-homes-and-home-care-teams-reduce-hospital-bed-blocking-evidence-from-portugal/ 2022-06-09T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Nurse.jpg https://www.openhealthgroup.com/insights/methicillin-resistant-staphylococcus-aureus-nosocomial-pneumonia-role-of-linezolid-in-the-peoples-republic-of-china/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Methicillin.png https://www.openhealthgroup.com/insights/physician-preferences-for-attributes-of-pediatric-combination-vaccines-in-the-united-states/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vaccine.png https://www.openhealthgroup.com/insights/prediagnosis-pathway-benchmarking-audit-in-patients-with-duchenne-muscular-dystrophy/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Duchenne-muscular-dystrophy.png https://www.openhealthgroup.com/insights/systematic-literature-review-of-trials-assessing-recommended-systemic-treatments-in-hepatocellular-carcinoma/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatocellular-carcinoma.png https://www.openhealthgroup.com/insights/treatment-patterns-and-economic-burden-among-cervical-and-endometrial-cancer-patients-newly-initiating-systemic-therapy/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-07-11-100625_gxmd.png https://www.openhealthgroup.com/insights/treatment-patterns-and-economic-burden-among-newly-diagnosed-cervical-and-endometrial-cancer-patients/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cervical-cancer.png https://www.openhealthgroup.com/insights/value-based-person-centred-integrated-care-for-frail-elderly-living-at-home-a-quasi-experimental-evaluation-using-multicriteria-decision-analysis/ 2022-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/elderly.png https://www.openhealthgroup.com/insights/conceptual-assessment-of-hrqol-among-japanese-non-metastatic-castration-resistant-prostate-cancer-nmcrpc-patients/ 2022-07-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer_2022-07-13-101141_oizx.png https://www.openhealthgroup.com/insights/treatment-patterns-and-real-world-clinical-outcomes-in-patients-with-advanced-endometrial-cancer-that-are-non-microsatellite-instability-high-non-msi-high-or-mismatch-repair-proficient-pmmr-in-the-uni/ 2022-07-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/endometrial-cancer.png https://www.openhealthgroup.com/insights/review-of-the-impact-of-nnrti-based-hiv-treatment-regimens-on-patient-reported-disease-burden/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV_2022-08-12-141828_rtop.png https://www.openhealthgroup.com/insights/survival-after-acute-episodes-of-immune-mediated-thrombotic-thrombocytopenic-purpura-ittp-cognitive-functioning-and-health-related-quality-of-life-impact-a-descriptive-cross-sectional-survey-of-adults/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/immune-mediated-thrombotic-thrombocytopenic-purpura.png https://www.openhealthgroup.com/insights/systematic-literature-review-of-current-treatments-for-stage-i-iii-merkel-cell-carcinoma/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Merkel-cell-carcinoma.png https://www.openhealthgroup.com/insights/systematic-literature-review-of-randomized-trials-comparing-antithrombotic-therapy-following-revascularization-procedures-in-patients-with-peripheral-artery-disease/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart_2022-08-12-124928_hfif.png https://www.openhealthgroup.com/insights/systematic-literature-review-of-the-disease-burden-and-vaccination-of-pneumococcal-disease-among-adults-in-select-asia-pacific-areas/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Streptococcus-pneumoniae.png https://www.openhealthgroup.com/insights/systematic-review-and-meta-analysis-of-pharmacological-therapies-for-painful-diabetic-peripheral-neuropathy/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/diabetes2.png https://www.openhealthgroup.com/insights/the-burden-of-managing-pleural-effusions-in-patients-with-chronic-myelogenous-leukemia-post-imatinib-failure-a-literature-based-economic-analysis/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leukaemia_2022-08-12-121612_cxkg.png https://www.openhealthgroup.com/insights/the-cystic-fibrosis-impact-questionnaire-qualitative-development-and-cognitive-evaluation-of-a-new-patient-reported-outcome-instrument-to-assess-the-life-impacts-of-cystic-fibrosis/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungs_2022-08-12-120946_xktp.jpg https://www.openhealthgroup.com/insights/the-non-anticoagulation-costs-of-atrial-fibrillation-management-findings-from-an-observational-study-in-nhs-primary-care/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atrial-fibrillation.png https://www.openhealthgroup.com/insights/the-uk-patient-experience-of-relapse-in-multiple-sclerosis-treated-with-first-disease-modifying-therapies/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MS.png https://www.openhealthgroup.com/insights/treatment-patterns1-anti-vascular-endothelial-growth-factor-and-laser-therapy-among-patients-with-diabetic-macular-edema/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/macular-edema_2022-08-12-112106_bqan.png https://www.openhealthgroup.com/insights/understanding-the-disease-course-and-therapeutic-benefit-of-tafamidis-across-real-world-studies-of-hereditary-transthyretin-amyloidosis-with-polyneuropathy-a-proof-of-concept-for-integrative-data-anal/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Nerve_2022-08-12-111732_pomj.png https://www.openhealthgroup.com/insights/what-outcomes-are-important-to-patients-with-long-term-conditions-a-discrete-choice-experiment/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-mart-production-7089401_2022-08-12-104359_ebgm.jpg https://www.openhealthgroup.com/insights/why-do-adults-value-eq-5d-y-3l-health-states-differently-for-themselves-than-for-children-and-adolescents-a-think-aloud-study/ 2022-08-11T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1906045933_2022-08-12-103829_brgf.jpg https://www.openhealthgroup.com/insights/psychometric-validation-of-the-eq-5d-3l-in-patients-with-nontuberculous-mycobacterial-ntm-lung-disease-caused-by-mycobacterium-avium-complex-mac/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lung-disease.png https://www.openhealthgroup.com/insights/psychometric-validation-of-the-eortc-qlq-hcc18-in-patients-with-previously-treated-unresectable-hepatocellular-carcinoma/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatocellular-carcinoma_2022-08-15-145306_tpwn.png https://www.openhealthgroup.com/insights/quality-adjusted-survival-with-combination-nab-paclitaxel-gemcitabine-vs-gemcitabine-alone-in-metastatic-pancreatic-cancer-a-q-twist-analysis/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pancreatic-cancer.png https://www.openhealthgroup.com/insights/real-world-burden-of-adverse-events-for-apalutamide-or-enzalutamide-treated-non-metastatic-castration-resistant-prostate-cancer-patients-in-the-united-states/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer1.png https://www.openhealthgroup.com/insights/real-world-clinical-and-economic-outcomes-associated-with-surgiflo-vs-floseal-in-cardiovascular-surgeries-in-the-us/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart1.png https://www.openhealthgroup.com/insights/real-world-comparison-of-healthcare-resource-utilization-and-costs-of-177-lulu-dota-tate-in-patients-with-progressive-neuroendocrine-tumors-in-england-a-matched-cohort-analysis-using-data-from-the-hos/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neuroendocrine.png https://www.openhealthgroup.com/insights/real-world-cost-effectiveness-of-primary-prophylaxis-with-g-csf-biosimilars-in-patients-at-intermediate-high-risk-of-febrile-neutropenia/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood_2022-08-15-104353_fpqm.png https://www.openhealthgroup.com/insights/real-world-outcomes-of-ivacaftor-treatment-in-people-with-cystic-fibrosis-a-systematic-review/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cystic-fibrosis.png https://www.openhealthgroup.com/insights/real-world-use-of-inhaled-nitric-oxide-therapy-in-patients-with-covid-19-and-mild-to-moderate-acute-respiratory-distress-syndrome/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/COVID-19.png https://www.openhealthgroup.com/insights/relationship-between-the-asthma-control-test-act-and-other-outcomes-a-targeted-literature-review/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungs-1.png https://www.openhealthgroup.com/insights/renal-function-changes-and-nhs-resource-use-in-breast-cancer-patients-with-metastatic-bone-disease-treated-with-iv-zoledronic-acid-or-oral-ibandronic-acid-a-four-centre-non-interventional-study/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/renal-function.png https://www.openhealthgroup.com/insights/resource-use-and-outcomes-associated-with-initiation-of-injectable-therapies-for-patients-with-type-2-diabetes-mellitus/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_2022-08-15-081017_yvwq.png https://www.openhealthgroup.com/insights/retrospective-database-analysis-to-explore-patterns-and-economic-burden-of-switchback-to-brand-after-generic-or-authorized-generic-utilization/ 2022-08-14T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/economic-evaluations_2022-08-15-075730_altf.png https://www.openhealthgroup.com/insights/modeling-the-economic-impact-of-linezolid-versus-vancomycin-in-confirmed-nosocomial-pneumonia-caused-by-methicillin-resistant-staphylococcus-aureus/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus-aureus_2022-08-16-140807_ixlj.png https://www.openhealthgroup.com/insights/modeling-the-cost-effectiveness-of-100-whey-based-partially-hydrolyzed-versus-cows-milk-infant-formula-in-the-prevention-of-atopic-dermatitis-in-singapore/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-15.png https://www.openhealthgroup.com/insights/modern-chemotherapy-management-of-recurrent-ovarian-cancer-a-multicentre-study/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Ovarian-cancer.png https://www.openhealthgroup.com/insights/personalized-cancer-medicine-in-the-media-sensationalism-or-realistic-reporting/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer.png https://www.openhealthgroup.com/insights/modification-of-treatment-sequence-model-with-a-customizable-number-of-treatments-to-better-reflect-contemporary-and-future-clinical-practice-in-moderate-to-severe-psoriasis/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriasis1.png https://www.openhealthgroup.com/insights/patient-characteristics-and-risk-factors-in-invasive-mold-infections-comparison-from-a-systematic-review-and-database-analysis/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/mold-infection.png https://www.openhealthgroup.com/insights/patient-perspectives-on-symptoms-health-related-quality-of-life-and-treatment-experience-associated-with-relapsed-refractory-multiple-myeloma/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor1.png https://www.openhealthgroup.com/insights/patient-reported-outcomes-in-individuals-with-hepatitis-c-virus-infection-treated-with-elbasvir-grazoprevir/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatitis-C_2022-08-16-074931_bods.png https://www.openhealthgroup.com/insights/patient-reported-complications-symptoms-and-experiences-of-living-with-x-linked-hypophosphatemia-across-the-life-course/ 2022-08-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor_2022-08-16-075339_tsvv.png https://www.openhealthgroup.com/insights/financial-toxicity-and-its-impact-on-health-outcomes-and-caregiver-burden-among-adult-cancer-survivors-in-the-usa/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer1.png https://www.openhealthgroup.com/insights/measuring-meaningful-benefit-risk-tradeoffs-to-promote-patient-focused-drug-development-in-prader-willi-syndrome-a-discrete-choice-experiment/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/drug-development.png https://www.openhealthgroup.com/insights/economic-outcomes-of-eszopiclone-treatment-in-insomnia-and-comorbid-major-depressive-disorder/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/insomnia.png https://www.openhealthgroup.com/insights/efficacy-tolerability-and-safety-of-aripiprazole-once-monthly-versus-other-long-acting-injectable-antipsychotic-therapies-in-the-maintenance-treatment-of-schizophrenia-a-mixed-treatment-comparison-of/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/clinical-trials.png https://www.openhealthgroup.com/insights/evaluating-the-cost-effectiveness-of-celecoxib-versus-ibuprofen-and-naproxen-in-patients-with-osteoarthritis-in-united-arab-emirates-based-on-the-precision-trial/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ibuprofen.png https://www.openhealthgroup.com/insights/factors-associated-with-non-use-and-sub-target-dosing-of-medical-therapy-for-heart-failure-with-reduced-ejection-fraction/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart-failure.png https://www.openhealthgroup.com/insights/feasibility-of-weekly-hiv-drug-delivery-to-enhance-drug-localization-in-lymphoid-tissues-based-on-pharmacokinetic-models-of-lipid-associated-indinavir/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV1.png https://www.openhealthgroup.com/insights/financial-toxicity-and-its-impact-on-health-outcomes-and-caregiver-burden-among-adult-cancer-survivors-in-the-usa/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer1.png https://www.openhealthgroup.com/insights/global-epidemiology-of-transthyretin-hereditary-amyloid-polyneuropathy-a-systematic-review/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/amyloid.png https://www.openhealthgroup.com/insights/glucocorticoid-management-of-adrenal-insufficiency-in-the-united-kingdom-assessment-using-real-world-data/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney1.png https://www.openhealthgroup.com/insights/health-related-quality-of-life-and-work-productivity-in-uk-patients-with-her2-positive-breast-cancer-a-cross-sectional-study-evaluating-the-relationships-between-disease-and-treatment-stage/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer2.png https://www.openhealthgroup.com/insights/injectable-hypomethylating-agents-for-management-of-myelodysplastic-syndromes-patients-perspectives-on-treatment/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myelodysplastic-syndromes.png https://www.openhealthgroup.com/insights/liver-resection-rate-following-downsizing-chemotherapy-with-cetuximab-in-metastatic-colorectal-cancer-uk-retrospective-observational-study/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemotherapy.png https://www.openhealthgroup.com/insights/long-term-assessment-of-healthcare-utilization-5-years-after-respiratory-syncytial-virus-infection-in-us-infants/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/virus.png https://www.openhealthgroup.com/insights/measuring-meaningful-benefit-risk-tradeoffs-to-promote-patient-focused-drug-development-in-prader-willi-syndrome-a-discrete-choice-experiment/ 2022-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/drug-development.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-anti-il-5-therapies-of-severe-eosinophilic-asthma-in-spain/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/asthma.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-aripiprazole-augmentation-treatment-of-patients-with-major-depressive-disorder-compared-to-olanzapine-and-quetiapine-augmentation-in-turkey-a-microsimulation-approach/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/depressive-disorder_2022-08-19-143941_cras.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-ocriplasmin-versus-watchful-waiting-for-treatment-of-symptomatic-vitreomacular-adhesion-in-the-us/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/eye-machiene.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-saxagliptin-as-oral-triple-therapy-with-metformin-and-a-sulfonylurea-in-the-management-of-type-2-diabetes-in-spain/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_2022-08-19-140355_qwfu.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-simeprevir-in-combination-with-peginterferon-and-ribavirin-for-treatment-naive-chronic-hepatitis-c-genotype-1-patients-in-japan/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-50.png https://www.openhealthgroup.com/insights/a-novel-approach-to-estimate-the-local-population-denominator-to-calculate-disease-incidence-for-hospital-based-health-events-in-england/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-49.png https://www.openhealthgroup.com/insights/patient-reported-outcomes-in-zuma-7-a-phase-3-study-of-axicabtagene-ciloleucel-in-second-line-large-b-cell-lymphoma/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lymphoma1.png https://www.openhealthgroup.com/insights/cost-effectiveness-and-budget-impact-of-venetoclax-in-combination-with-rituximab-in-relapsed-refractory-chronic-lymphocytic-leukemia-in-switzerland/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leukaemia_2022-08-19-132842_dqcy.png https://www.openhealthgroup.com/insights/cost-effectiveness-model-of-long-acting-risperidone-in-schizophrenia-in-the-us/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/schizophrenia_2022-08-19-132448_spem.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-axicabtagene-ciloleucel-versus-lisocabtagene-maraleucel-for-adult-patients-with-relapsed-or-refractory-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy-in-the-us/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lymphoma.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-dapagliflozin-versus-dpp-4-inhibitors-as-monotherapy-in-the-treatment-of-type-2-diabetes-mellitus-from-a-uk-health-care-perspective/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes5.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-linezolid-versus-vancomycin-among-patients-with-methicillin-resistant-staphylococcus-aureus-confirmed-nosocomial-pneumonia-in-china/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/staphylococcus.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-partially-hydrolyzed-whey-protein-formula-in-the-primary-prevention-of-atopic-dermatitis-in-at-risk-urban-filipino-infants/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/dermatitis.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-statin-therapy-for-secondary-prevention-among-patients-with-coronary-artery-disease-and-baseline-ldl-c-70-100-mg-dl-in-taiwan/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/coronary-artery-disease.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-the-15-valent-pneumococcal-conjugate-vaccine-for-high-risk-adults-in-switzerland/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vaccine1.png https://www.openhealthgroup.com/insights/cost-utility-analysis-of-genotype-guided-antiplatelet-therapy-in-patients-with-moderate-to-high-risk-acute-coronary-syndrome-and-planned-percutaneous-coronary-intervention/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/dna.png https://www.openhealthgroup.com/insights/cross-cultural-validity-of-the-thyroid-specific-quality-of-life-patient-reported-outcome-measure-thypro/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/thyroid1.png https://www.openhealthgroup.com/insights/current-management-of-atrial-fibrillation-an-observational-study-in-nhs-primary-care/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atrial-fibrillation1.png https://www.openhealthgroup.com/insights/desirability-and-acceptability-of-a-treatment-sequencing-model-in-relapsing-remitting-multiple-sclerosis-a-health-technology-assessment-perspective/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-e1523541695217.jpeg https://www.openhealthgroup.com/insights/development-of-the-symptoms-and-impacts-questionnaire-for-crohns-disease-and-ulcerative-colitis/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Crohns-disease.png https://www.openhealthgroup.com/insights/direct-healthcare-resource-utilisation-health-related-quality-of-life-and-work-productivity-in-patients-with-moderate-rheumatoid-arthritis-an-observational-study/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/rheumatoid-arthritis1.png https://www.openhealthgroup.com/insights/economic-and-humanistic-burden-of-cervical-cancer-in-the-united-states-results-from-a-nationally-representative-survey/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cervical-cancer1.png https://www.openhealthgroup.com/insights/economic-assessment-of-delaying-insulin-treatment-through-the-use-of-newer-anti-diabetic-agents-dapagliflozin-forxiga-and-exenatide-bydureon-both-as-add-on-to-metformin-a-cost-effectiveness-analysis-f/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/insulin.png https://www.openhealthgroup.com/insights/economic-burden-of-haematological-adverse-effects-in-cancer-patients-a-systematic-review/ 2022-08-18T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-cells_2022-08-19-105021_ahok.png https://www.openhealthgroup.com/insights/an-evaluation-of-the-psychometric-properties-of-the-sf-12v2-health-survey-among-adults-with-hemophilia/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/blood-cells1.png https://www.openhealthgroup.com/insights/antibacterial-treatment-of-meticillin-resistant-staphylococcus-aureus-complicated-skin-and-soft-tissue-infections-a-cost-and-budget-impact-analysis-in-greek-hospitals/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Staphylococcus1.png https://www.openhealthgroup.com/insights/clinical-and-economic-analysis-of-outcomes-of-dose-tapering-or-withdrawal-of-tumor-necrosis-factor-%ce%b1-inhibitors-upon-achieving-stable-disease-activity-in-rheumatoid-arthritis-patients/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/rheumatoid-arthritis2_2022-08-22-153025_qatu.png https://www.openhealthgroup.com/insights/colorectal-cancer-screening-an-updated-modeling-study-for-the-us-preventive-services-task-force/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Colorectal-cancer.png https://www.openhealthgroup.com/insights/comparability-of-european-league-against-rheumatology-recommended-pharmacological-treatments-of-oral-ulcers-associated-with-behcets-disease-a-systematic-literature-review-of-randomized-controlled-tria/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/oral-ulcers.png https://www.openhealthgroup.com/insights/comparison-of-clinical-outcomes-of-edoxaban-versus-apixaban-dabigatran-rivaroxaban-and-vitamin-k-antagonists-in-patients-with-atrial-fibrillation-in-germany-a-real-world-cohort-study/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atrial-fibrillation2.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-fesoterodine-and-tolterodine-for-the-treatment-of-overactive-bladder-with-urge-urinary-incontinence-in-spain-and-finland/ 2022-08-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bladder1.png https://www.openhealthgroup.com/insights/a-systematic-literature-review-of-disease-burden-and-clinical-efficacy-for-patients-with-relapsed-or-refractory-acute-myeloid-leukemia/ 2022-08-22T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myeloid-leukemia.png https://www.openhealthgroup.com/insights/acute-treatment-of-migraine-with-celecoxib-oral-solution-results-of-a-randomized-placebo-controlled-clinical-trial/ 2022-08-22T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine.png https://www.openhealthgroup.com/insights/an-assessment-of-clinically-important-differences-on-the-worst-pain-severity-item-of-the-modified-brief-pain-inventory-in-patients-with-diabetic-peripheral-neuropathic-pain/ 2022-08-22T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/peripheral-neuropathic-pain.png https://www.openhealthgroup.com/insights/an-economic-model-to-compare-linezolid-and-vancomycin-for-the-treatment-of-confirmed-methicillin-resistant-staphylococcus-aureus-nosocomial-pneumonia-in-germany/ 2022-08-22T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pneumonia.png https://www.openhealthgroup.com/insights/a-guide-to-selecting-flexible-survival-models-to-inform-economic-evaluations-of-cancer-immunotherapies/ 2022-08-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer2.png https://www.openhealthgroup.com/insights/major-variation-in-hepatocellular-carcinoma-treatment-and-outcomes-in-england-a-retrospective-cohort-study/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hepatocellular-carcinoma_2022-08-25-145209_bhqd.png https://www.openhealthgroup.com/insights/current-management-of-secondary-progressive-multiple-sclerosis-in-the-uk-a-multiple-sclerosis-specialist-nurse-perspective/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MS_2022-08-25-144655_wtjx.png https://www.openhealthgroup.com/insights/implications-of-systemic-adjuvant-melanoma-treatments-for-u-k-melanoma-services-results-of-the-u-k-melanoma-adjuvant-pathway-survey/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Melanoma.png https://www.openhealthgroup.com/insights/indirect-comparison-of-48-week-efficacy-and-safety-of-long-acting-cabotegravir-and-rilpivirine-maintenance-every-8-weeks-with-daily-oral-standard-of-care-antiretroviral-therapy-in-participants-with-vi/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV1_2023-04-18-080920_aaji.png https://www.openhealthgroup.com/insights/the-budget-impact-of-enzyme-replacement-therapy-in-type-1-gaucher-disease-in-the-united-states/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Gaucher-disease.png https://www.openhealthgroup.com/insights/real-world-effectiveness-of-belimumab-in-systemic-lupus-erythematosus-a-systematic-literature-review/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/antibody.png https://www.openhealthgroup.com/insights/burden-of-illness-of-aromatic-l-amino-acid-decarboxylase-deficiency-a-survey-of-physicians-in-southern-europe/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/burden-of-illness.png https://www.openhealthgroup.com/insights/cost-effectiveness-analysis-of-kte-x19-car-t-therapy-versus-real-world-standard-of-care-in-patients-with-relapsed-refractory-mantle-cell-lymphoma-post-btki-in-england/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lymphoma2.png https://www.openhealthgroup.com/insights/a-need-for-implementation-science-to-optimise-the-use-of-evidence-based-interventions-in-hiv-care-a-systematic-literature-review/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV3.png https://www.openhealthgroup.com/insights/a-quality-adjusted-survival-time-without-symptoms-or-toxicities-analysis-of-glasdegib-plus-low-dose-cytarabine-versus-low-dose-cytarabine-as-initial-therapy-for-acute-myeloid-leukemia-in-patients-who/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chemotherapy1.png https://www.openhealthgroup.com/insights/a-retrospective-observational-research-study-to-describe-the-real-world-use-of-bosutinib-in-patients-with-chronic-myeloid-leukemia-in-the-united-kingdom-and-the-netherlands/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/myeloid-leukemia1.png https://www.openhealthgroup.com/insights/a-retrospective-real-world-study-of-the-current-treatment-pathways-for-myelofibrosis-in-the-united-kingdom-the-realism-uk-study/ 2022-08-24T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cancer3.png https://www.openhealthgroup.com/insights/statin-intake-and-all-cause-mortality-among-older-nursing-home-residents/ 2022-08-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nursing-home-residents.png https://www.openhealthgroup.com/insights/treatment-patterns-and-outcomes-among-nontransplant-newly-diagnosed-multiple-myeloma-patients-in-spain/ 2022-08-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-myeloma_2022-08-26-135046_ihsn.png https://www.openhealthgroup.com/insights/risk-predictors-and-symptom-features-of-long-covid-within-a-broad-primary-care-patient-population-including-both-tested-and-untested-patients/ 2022-08-30T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/COVID-191.png https://www.openhealthgroup.com/insights/effects-of-levodopa-carbidopa-intestinal-gel-on-dyskinesia-and-non-motor-symptoms-including-sleep-results-from-a-meta-analysis-with-24-month-follow-up/ 2022-09-05T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/older-adult_2022-09-06-124932_tpnc.png https://www.openhealthgroup.com/insights/risk-factors-in-people-with-mold-infections-that-have-spread-to-different-parts-of-the-body-a-plain-language-summary/ 2022-09-05T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/mold-infection2.png https://www.openhealthgroup.com/insights/cervical-cancer-screening-guidelines-and-screening-practices-in-11-countries-a-systematic-literature-review-2/ 2022-09-05T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cervical-cancer2.png https://www.openhealthgroup.com/insights/a-canadian-cost-utility-analysis-of-2-trabecular-microbypass-stents-at-time-of-cataract-surgery-in-patients-with-mild-to-moderate-open-angle-glaucoma/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glaucoma1.png https://www.openhealthgroup.com/insights/a-cost-per-responder-model-for-abatacept-versus-adalimumab-among-rheumatoid-arthritis-patients-with-seropositivity/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rheumatoid-arthritis_2022-09-08-124852_ybev.png https://www.openhealthgroup.com/insights/cardiovascular-healthcare-cost-savings-associated-with-increased-whole-grains-consumption-among-adults-in-the-united-states/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2022-09-08-124123_vblw.png https://www.openhealthgroup.com/insights/economic-and-humanistic-burden-associated-with-noncommunicable-diseases-among-adults-with-depression-and-anxiety-in-the-united-states/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/General.png https://www.openhealthgroup.com/insights/impact-of-non-cardiac-clinicopathologic-characteristics-on-survival-in-transthyretin-amyloid-polyneuropathy/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Nerve_2022-09-08-111054_nyos.png https://www.openhealthgroup.com/insights/the-eq-5d-5l-value-set-for-england-response-to-the-quality-assurance/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor_2022-09-08-105504_isaz.png https://www.openhealthgroup.com/insights/corneal-cross-linking-versus-conventional-management-for-keratoconus-a-lifetime-economic-model/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/keratoconus.png https://www.openhealthgroup.com/insights/evaluating-complex-health-and-social-care-program-using-multi-criteria-decision-analysis-a-case-study-of-better-together-in-amsterdam-north/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/social-care.png https://www.openhealthgroup.com/insights/early-versus-later-use-of-vedolizumab-in-ibd-patient-characteristics-and-treatment-patterns-in-the-real-world-ralee/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/bowel_2022-09-08-095150_xckz.png https://www.openhealthgroup.com/insights/2-year-real-world-outcomes-with-intravitreal-aflibercept-in-neovascular-age-related-macular-degeneration-literature-review-and-meta-analysis-of-patient-relevant-outcomes/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/macular-edema_2022-09-08-094345_rkon.png https://www.openhealthgroup.com/insights/a-cost-effectiveness-analysis-of-istent-inject-combined-with-phacoemulsification-cataract-surgery-in-patients-with-mild-to-moderate-open-angle-glaucoma-in-france/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glaucoma.png https://www.openhealthgroup.com/insights/adjunctive-use-of-statins-for-covid-19/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/COVID-19_2022-09-08-092924_xnsv.png https://www.openhealthgroup.com/insights/economic-and-humanistic-burden-associated-with-depression-and-anxiety-among-adults-with-non-communicable-chronic-diseases-nccds-in-the-united-states/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/marek-levak-GNVxujZ_CxU-unsplash_2022-09-08-092458_mfow.jpg https://www.openhealthgroup.com/insights/hospital-admissions-for-stroke-and-bleeding-in-hounslow-following-a-quality-improvement-initiative/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stroke1.png https://www.openhealthgroup.com/insights/hospital-mortality-in-covid-19-patients-in-belgium-treated-with-statins-ace-inhibitors-and-or-arbs/ 2022-09-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/COVID-192.png https://www.openhealthgroup.com/insights/epidemiological-and-clinical-characteristics-of-persons-with-transthyretin-hereditary-amyloid-polyneuropathy-a-global-synthesis-of-532-cases/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/polyneuropathy.png https://www.openhealthgroup.com/insights/going-paperless-a-new-era-for-patient-reported-outcome-measures-in-dermatology/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/paperless.png https://www.openhealthgroup.com/insights/cost-per-response-analysis-of-strategies-for-chronic-immune-thrombocytopenia/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PLATELISTS.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-perampanel-for-the-treatment-of-primary-generalized-tonic-clonic-seizures-pgtcs-in-epilepsy-a-spanish-perspective/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/epilepsy.png https://www.openhealthgroup.com/insights/cost-minimization-analysis-of-alemtuzumab-compared-to-fingolimod-and-natalizumab-for-the-treatment-of-active-relapsing-remitting-multiple-sclerosis-in-the-netherlands/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multiple-sclerosis_2022-09-13-122204_ihfy.png https://www.openhealthgroup.com/insights/a-retrospective-observational-study-of-early-experiences-of-vedolizumab-treatment-for-inflammatory-bowel-disease-in-the-uk-the-revive-study/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bowel-red_2022-09-13-121542_cizv.png https://www.openhealthgroup.com/insights/an-exploratory-phenome-wide-association-study-linking-asthma-and-liver-disease-genetic-variants-to-electronic-health-records-from-the-estonian-biobank/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/liver.png https://www.openhealthgroup.com/insights/multiple-treatment-comparison-in-narcolepsy-a-network-meta-analysis-methodological-concerns/ 2022-09-12T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/sleep.png https://www.openhealthgroup.com/insights/the-clinical-impact-of-multiple-prevention-strategies-for-respiratory-syncytial-virus-infections-in-infants-and-high-risk-toddlers-in-the-united-states/ 2022-09-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/respiratory-syncytial-virus.png https://www.openhealthgroup.com/insights/48-week-efficacy-and-safety-of-dolutegravir-relative-to-commonly-used-third-agents-in-treatment-naive-hiv-1-infected-patients-a-systematic-review-and-network-meta-analysis/ 2022-09-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV_2022-09-20-140533_eoew.png https://www.openhealthgroup.com/insights/healthcare-burden-and-costs-associated-with-urinary-tract-infections-in-type-2-diabetes-mellitus-patients-an-analysis-based-on-a-large-sample-of-456-586-german-patients/ 2022-09-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Diabetes_2022-09-20-135832_rbgs.png https://www.openhealthgroup.com/insights/the-impact-of-the-introduction-of-fidaxomicin-on-the-management-of-clostridium-difficile-infection-in-seven-nhs-secondary-care-hospitals-in-england-a-series-of-local-service-evaluations/ 2022-09-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hospital.png https://www.openhealthgroup.com/insights/cost-and-clinical-benefits-associated-with-oncotype-dx-test-in-patients-with-early-stage-hr-her2-node-negative-breast-cancer-in-the-netherlands/ 2022-09-29T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer_2022-09-30-093545_raum.png https://www.openhealthgroup.com/insights/human-papillomavirus-vaccine-impact-and-effectiveness-in-six-high-risk-populations-a-systematic-literature-review/ 2022-10-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HPV.png https://www.openhealthgroup.com/insights/impact-of-hypomethylating-agent-use-on-hospital-and-emergency-room-visits-and-predictors-of-early-discontinuation-in-patients-with-higher-risk-myelodysplastic-syndromes/ 2022-10-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hospital3.png https://www.openhealthgroup.com/insights/continued-posttrial-benefits-of-buprenorphine-extended-release-recover-study-findings/ 2022-10-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pills_2022-10-17-122438_qetx.png https://www.openhealthgroup.com/insights/understanding-what-matters-to-metastatic-castration-resistant-prostate-cancer-mcrpc-patients-when-considering-treatment-options-a-us-patient-preference-survey/ 2022-10-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/prostate-cancer_2022-10-17-120208_zoco.png https://www.openhealthgroup.com/insights/a-policy-review-of-the-introduction-of-the-menacwy-vaccine-in-toddlers-across-multiple-countries/ 2022-10-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vaccine_2022-10-26-123142_naad.png https://www.openhealthgroup.com/insights/toward-the-optimized-assessment-of-clinical-outcomes-in-studies-of-novel-treatments-for-alzheimers-disease/ 2022-12-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan_2022-12-19-104514_fjyt.png https://www.openhealthgroup.com/insights/the-long-term-healthcare-utilization-and-economic-burden-of-rsv-infection-in-children-5-years-in-japan-propensity-score-matched-cohort-study/ 2022-12-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RSV-inf-japan.png https://www.openhealthgroup.com/insights/real-world-clinical-effectiveness-and-safety-of-ct-p10-in-patients-with-diffuse-large-b-cell-lymphoma-an-observational-study-in-europe/ 2022-12-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lymphoma.jpg https://www.openhealthgroup.com/insights/real-world-evidence-of-long-term-survival-and-healthcare-resource-use-in-patients-with-hepatic-encephalopathy-receiving-rifaximin-%ce%b1-treatment-a-retrospective-observational-extension-study-with-lo/ 2022-12-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hospital_2022-12-19-105348_wjab.png https://www.openhealthgroup.com/insights/hypothetical-versus-experienced-health-state-valuation-a-qualitative-study-of-adult-general-public-views-and-preferences/ 2022-12-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor_2022-12-19-105023_szla.png https://www.openhealthgroup.com/insights/clinical-evidence-of-interventions-assessed-in-friedreich-ataxia-a-systematic-review/ 2022-12-23T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neurodegenerative.png https://www.openhealthgroup.com/insights/considerations-for-the-utility-of-real-world-evidence-beyond-trial-data-in-advanced-nsclc-the-case-of-frontline-tyrosine-kinase-inhibitors/ 2023-01-11T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/tyrosine-kinase-inhibitors.png https://www.openhealthgroup.com/insights/development-of-an-innovative-sql-based-approach-to-identify-potential-patients-with-neurotransmitter-disorders/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neurotransmitter.png https://www.openhealthgroup.com/insights/hemolytic-disease-of-the-fetus-and-newborn-systematic-literature-review-of-the-antenatal-landscape/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/fetus.png https://www.openhealthgroup.com/insights/variation-in-access-to-specialist-services-for-neurosurgical-procedures-in-adults-with-epilepsy-in-england-a-cohort-study/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan_2023-02-06-102347_cpyu.png https://www.openhealthgroup.com/insights/quality-adjusted-time-without-symptoms-or-toxicity-analysis-of-axicabtagene-ciloleucel-versus-standard-of-care-in-patients-with-relapsed-refractory-large-b-ell-lymphoma-q-twist-analysis-of-axi-cel-ver/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lymphoma2_2023-02-06-101416_jyyz.png https://www.openhealthgroup.com/insights/a-probabilistic-cost-effectiveness-analysis-of-venetoclax-and-obinutuzumab-as-a-first-line-therapy-in-chronic-lymphocytic-leukemia-in-canada/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leukaemia_2023-02-06-100757_arnp.png https://www.openhealthgroup.com/insights/delphi-panel-for-consensus-on-the-optimal-management-of-dabrafenib-plus-trametinib-related-pyrexia-in-patients-with-melanoma/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Melanoma_2023-02-06-100511_igza.png https://www.openhealthgroup.com/insights/treatment-patterns-and-real-world-clinical-outcomes-in-patients-with-advanced-endometrial-cancer-who-are-microsatellite-instability-msi-high-or-are-mismatch-repair-deficient-dmmr-in-the-united-states/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/endometrial-cancer_2023-02-06-100037_qhhv.png https://www.openhealthgroup.com/insights/the-impact-of-treatment-resistant-depression-on-the-lives-of-carers-a-mixed-methods-study/ 2023-02-06T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/caregivers.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-nivolumab-plus-ipilimumab-for-the-first-line-treatment-of-intermediate-poor-risk-advanced-and-or-metastatic-renal-cell-carcinoma-in-switzerland/ 2023-03-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/metastatic-renal-cell-carcinoma.png https://www.openhealthgroup.com/insights/european-delphi-panel-to-build-consensus-on-tapering-and-discontinuing-thrombopoietin-receptor-agonists-in-immune-thrombocytopenia/ 2023-03-16T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/White-blood-cell.png https://www.openhealthgroup.com/insights/a-retrospective-cohort-study-comparing-clinical-outcomes-and-healthcare-resource-utilisation-in-patients-undergoing-surgery-for-osteomyelitis-in-england-a-case-for-reorganising-orthopaedic-infection-s/ 2023-05-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ortho.png https://www.openhealthgroup.com/insights/quality-adjusted-time-without-symptoms-or-toxicity-analysis-of-nivolumab-plus-chemotherapy-versus-chemotherapy-alone-for-the-management-of-previously-untreated-patients-with-advanced-gastric-cancer-ga/ 2023-05-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-2023-05-08T152349.354.png https://www.openhealthgroup.com/insights/an-indirect-comparison-of-144-week-efficacy-safety-and-tolerability-of-dolutegravir-plus-lamivudine-and-second-generation-integrase-inhibitor-based-3-drug-single-tablet-regimens-in-therapy-naive-peopl/ 2023-05-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV4.png https://www.openhealthgroup.com/insights/patient-reported-experiences-with-migraine-related-cognitive-symptoms-results-of-the-micoas-qualitative-study/ 2023-05-07T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine1.png https://www.openhealthgroup.com/insights/antimicrobial-use-for-the-management-of-varicella-in-thailand-a-retrospective-observational-study/ 2023-05-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/microbes.png https://www.openhealthgroup.com/insights/unmet-needs-of-people-with-epilepsy-a-qualitative-study-exploring-their-journey-from-presentation-to-long-term-management-across-five-european-countries/ 2023-05-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-hand.png https://www.openhealthgroup.com/insights/modeling-monthly-migraine-day-distributions-using-longitudinal-regression-models-and-linking-quality-of-life-to-inform-cost-effectiveness-analysis-a-case-study-of-fremanezumab-in-japanese-korean-migra/ 2023-06-15T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine_2023-06-16-114842_clym.png https://www.openhealthgroup.com/insights/the-value-of-treatment-for-infertility-a-systematic-literature-review-of-willingness-to-pay-thresholds-and-approaches-for-determining-the-cost-effectiveness-of-fertility-therapies/ 2023-06-19T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/fertility_2023-06-20-131225_hnjy.png https://www.openhealthgroup.com/insights/because-it-is-a-rare-disease-it-needs-to-be-brought-to-attention-that-there-are-things-out-of-the-norm-a-qualitative-study-of-patient-and-physician-experiences-of-wilson-disease-diagnosis-and-manageme/ 2023-07-02T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Wilsons-disease_2023-07-03-112021_nwqw.png https://www.openhealthgroup.com/insights/priority-acute-and-preventive-migraine-treatment-benefits-results-of-the-migraine-clinical-outcome-assessment-system-micoas-qualitative-study-of-people-living-with-migraine-2/ 2023-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pediatric-neurology_2023-07-11-133343_piin.png https://www.openhealthgroup.com/insights/challenges-in-conducting-fractional-polynomial-and-standard-parametric-network-meta-analyses-of-immune-checkpoint-inhibitors-for-first-line-advanced-renal-cell-carcinoma/ 2023-07-10T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Untitled-design-2-1.png https://www.openhealthgroup.com/insights/delphi-panel-to-obtain-clinical-consensus-about-using-long-acting-injectable-antipsychotics-to-treat-first-episode-and-early-phase-schizophrenia-treatment-goals-and-approaches-to-functional-recovery/ 2023-07-31T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/injectables.png https://www.openhealthgroup.com/insights/budget-impact-analysis-of-a-digital-monitoring-platform-for-copd/ 2023-07-31T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Chronic-obstructive-pulmonary-disease.png https://www.openhealthgroup.com/insights/anticoagulant-treatment-adherence-and-persistence-in-german-patients-with-atrial-fibrillation/ 2023-07-31T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atrial-fibrillation3.png https://www.openhealthgroup.com/insights/a-real-world-study-of-the-first-use-of-palbociclib-for-the-treatment-of-advanced-breast-cancer-within-the-uk-national-health-service-as-part-of-the-novel-ibrance-patient-program/ 2023-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer3.png https://www.openhealthgroup.com/insights/the-burden-of-ovarian-cancer-in-the-usa-from-2007-to-2018-evidence-from-the-medical-expenditure-panel-survey/ 2023-08-16T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Ovarian-cancer_2023-08-17-130445_ygrk.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-pneumococcal-vaccination-in-adults-in-italy-comparing-new-alternatives-and-exploring-the-role-of-gmt-ratios-in-informing-vaccine-effectiveness/ 2023-08-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Vaccines-images_cropped.png https://www.openhealthgroup.com/insights/psychosocial-health-modifies-associations-between-hpa-axis-function-and-brain-structure-in-older-age/ 2023-08-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan_2023-08-24-123234_geqk.png https://www.openhealthgroup.com/insights/matching-adjusted-indirect-comparison-of-the-long-term-efficacy-of-deucravacitinib-versus-adalimumab-for-moderate-to-severe-plaque-psoriasis/ 2023-08-23T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriasis_2023-08-24-122458_tlta.png https://www.openhealthgroup.com/insights/retrospective-comparison-of-survival-projections-for-car-t-cell-therapies-in-large-b-cell-lymphoma/ 2023-09-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/large-B-Cell-lymphoma.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-nivolumab-and-ipilimumab-versus-pembrolizumab-and-axitinib-in-advanced-renal-cell-carcinoma-with-intermediate-or-poor-prognostic-risk-a-brazilian-private-healthcare-system-perspe/ 2023-09-21T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Renal-cell-carcinoma_2023-09-22-132145_mkum.png https://www.openhealthgroup.com/insights/assessing-response-in-atopic-dermatitis-a-systematic-review-of-the-psychometric-performance-of-measures-used-in-htas-and-clinical-trials/ 2023-09-25T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-doc.png https://www.openhealthgroup.com/insights/terlipressin-versus-midodrine-plus-octreotide-for-hepatorenal-sy-ndrome-acute-kidney-injury-a-propensity-score-matched-comparison/ 2023-10-01T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney_2023-10-02-132553_vlji.png https://www.openhealthgroup.com/insights/epidemiology-of-medically-attended-respiratory-syncytial-virus-lower-respiratory-tract-infection-in-japanese-children-2011-2017/ 2023-10-01T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/respiratory-syncytial-virus_2023-10-02-132157_cntl.png https://www.openhealthgroup.com/insights/real-world-effectiveness-satisfaction-and-optimization-of-ubrogepant-for-the-acute-treatment-of-migraine-in-combination-with-onabotulinumtoxina-results-from-the-courage-study/ 2023-10-01T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine_2023-10-02-131742_umzr.png https://www.openhealthgroup.com/insights/a-review-of-evidence-for-pneumococcal-vaccination-in-adults-at-increased-risk-of-pneumococcal-disease-risk-group-definitions-and-optimization-of-vaccination-coverage-in-the-united-kingdom/ 2023-10-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vaccine_2023-10-18-144513_cxll.png https://www.openhealthgroup.com/insights/association-between-intermediate-end-points-progression-free-survival-and-overall-survival-in-first-line-advanced-or-recurrent-endometrial-cancer/ 2023-10-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/endometrial-cancer_2023-10-18-143818_mdig.png https://www.openhealthgroup.com/insights/the-lived-experience-of-major-and-treatment-resistant-depression-in-england-a-mixed-methods-study/ 2023-10-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain_2023-10-18-131335_sgkn.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-terlipressin-for-hepatorenal-syndrome-the-united-states-hospital-perspective/ 2023-10-17T23:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/billing_2023-10-18-130644_gybc.png https://www.openhealthgroup.com/insights/perspectives-of-healthcare-professionals-on-the-management-and-treatment-of-advanced-ovarian-cancer-in-the-uk-results-from-the-know-oc-survey/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Ovarian-cancer_2023-12-05-125052_ecbx.png https://www.openhealthgroup.com/insights/hemolytic-disease-of-the-fetus-and-newborn-rapid-review-of-postnatal-care-and-outcomes/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hemolytic-disease.png https://www.openhealthgroup.com/insights/epidemiology-and-burden-of-dengue-fever-in-the-united-states-a-systematic-review/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/littrature-review.png https://www.openhealthgroup.com/insights/adolescent-and-caregiver-preferences-for-juvenile-idiopathic-arthritis-treatment-a-discrete-choice-experiment/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/arthritis.png https://www.openhealthgroup.com/insights/opicapone-versus-entacapone-head-to-head-retrospective-data-based-comparison-of-healthcare-resource-utilization-in-people-with-parkinsons-disease-new-to-catechol-o-methyltransferase-comt-inhibitor-tre/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Parkinsons_2023-12-05-121536_vweq.png https://www.openhealthgroup.com/insights/evaluating-therapeutic-benefits-of-ubrogepant-via-latent-class-models-a-post-hoc-exploratory-analysis-of-the-achieve-i-and-achieve-ii-trials/ 2023-12-05T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/headach.png https://www.openhealthgroup.com/insights/discrete-choice-experiment-dce-to-quantify-the-influence-of-trial-features-on-the-decision-to-participate-in-cystic-fibrosis-cf-clinical-trials/ 2023-12-13T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cystic-fibrosis_2023-12-13-085326_dfgp.png https://www.openhealthgroup.com/insights/real-world-use-of-ubrogepant-as-acute-treatment-for-migraine-with-an-anti-calcitonin-gene-related-peptide-monoclonal-antibody-results-from-courage/ 2023-12-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain_2023-12-19-134646_hdsf.png https://www.openhealthgroup.com/insights/terlipressin-versus-midodrine-plus-octreotide-for-hepatorenal-syndrome-acute-kidney-injury-a-propensity-score-matched-comparison/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney_2024-01-19-153708_mcnv.png https://www.openhealthgroup.com/insights/development-and-validation-of-a-photonumeric-scale-to-assess-marionette-lines/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/stroke1_2024-01-19-153345_gydw.png https://www.openhealthgroup.com/insights/economic-and-humanistic-burden-in-paediatric-patients-with-atopic-dermatitis/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atopic-dermatitis_2024-01-19-152156_kotb.png https://www.openhealthgroup.com/insights/using-the-online-elicitation-of-personal-utility-functions-opuf-approach-to-derive-a-patient-based-eq-5d-5l-value-set-a-study-in-122-patients-with-rheumatic-diseases-from-germany/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/littrature-review_2024-01-19-145150_wzpc.png https://www.openhealthgroup.com/insights/patients-willingness-to-accept-adverse-event-and-cost-tradeoffs-from-oral-nicotinamide-for-reduced-risk-of-non-melanoma-skin-cancer/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/caregivers_2024-01-19-143823_vuvn.png https://www.openhealthgroup.com/insights/clinical-economic-and-humanistic-burden-of-community-acquired-pneumonia-in-europe-a-systematic-literature-review/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor_2024-01-19-133706_muax.png https://www.openhealthgroup.com/insights/long-term-outcomes-of-eladocagene-exuparvovec-compared-with-standard-of-care-in-aromatic-l-amino-acid-decarboxylase-aadc-deficiency-a-modelling-study/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor1_2024-01-19-133356_oanc.png https://www.openhealthgroup.com/insights/population-health-model-predicting-the-long-term-impact-of-sotatercept-on-morbidity-and-mortality-in-patients-with-pulmonary-arterial-hypertension-pah/ 2024-01-19T00:00:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart2_2024-01-19-132811_bfsy.png https://www.openhealthgroup.com/insights/the-impacts-of-migraine-on-functioning-results-from-two-qualitative-studies-of-people-living-with-migraine/ 2024-03-25T21:14:35+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine1_2024-03-05-120302_vnkc_bc9e4c42e52fd22ff41eda620350ec20.png https://www.openhealthgroup.com/insights/making-use-of-technology-to-improve-stated-preference-studies/ 2024-05-30T13:37:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/General_2024-04-24-123326_sreg_bc9e4c42e52fd22ff41eda620350ec20.png https://www.openhealthgroup.com/insights/clinical-and-economic-value-of-a-biosimilar-portfolio-to-stakeholders-an-integrative-literature-review/ 2024-05-30T13:42:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_332560013_bc9e4c42e52fd22ff41eda620350ec20.jpg https://www.openhealthgroup.com/insights/cost-effectiveness-of-fremanezumab-in-episodic-and-chronic-migraine-patients-from-a-japanese-healthcare-perspective/ 2024-06-27T11:01:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_332560013_bc9e4c42e52fd22ff41eda620350ec20.jpg https://www.openhealthgroup.com/insights/real-world-prevalence-of-microsatellite-instability-testing-and-related-status-in-women-with-advanced-endometrial-cancer-in-europe/ 2024-06-27T11:15:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/endometrial-cancer-1.png https://www.openhealthgroup.com/insights/real-world-treatment-patterns-and-clinical-outcomes-from-a-retrospective-chart-review-study-of-patients-with-recurrent-or-advanced-endometrial-cancer-who-progressed-following-prior-systemic-therapy-in/ 2024-06-27T11:19:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/breast-cancer3-1.png https://www.openhealthgroup.com/insights/physician-and-professional-caregiver-perspectives-on-meaningful-change-to-agitation-behaviors-in-alzheimers-dementia-insights-from-qualitative-interviews/ 2024-06-27T11:32:44+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nursing-home-residents-1.png https://www.openhealthgroup.com/insights/review-on-epidemiology-disease-burden-and-treatment-patterns-of-iga-nephropathy-in-select-apac-countries/ 2024-06-27T11:36:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nephropathy.png https://www.openhealthgroup.com/insights/a-retrospective-observational-study-on-characteristics-treatment-patterns-and-healthcare-resource-use-of-patients-with-myasthenia-gravis-in-england/ 2024-06-27T11:53:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-1.png https://www.openhealthgroup.com/insights/it-takes-two-to-tango-setting-out-the-conditions-in-which-performance-based-risk-sharing-arrangements-work-for-both-parties/ 2024-06-27T12:01:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-doc-3.png https://www.openhealthgroup.com/insights/comparative-effectiveness-of-sotrovimab-versus-no-treatment-in-non-hospitalised-high-risk-covid-19-patients-in-north-west-london-a-retrospective-cohort-study/ 2024-06-27T12:11:23+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungss.png https://www.openhealthgroup.com/insights/real-world-effectiveness-of-high-dose-tafamidis-on-neurologic-disease-progression-in-mixed-phenotype-variant-transthyretin-amyloid-cardiomyopathy/ 2024-08-01T00:49:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Web-page-header-image.jpg https://www.openhealthgroup.com/insights/accurate-consensus-reporting-document-accord-explanation-and-elaboration-guidance-and-examples-to-support-reporting-consensus-methods-2/ 2024-10-29T20:38:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/littrature-review_2024-01-19-145150_wzpc.png https://www.openhealthgroup.com/insights/comparison-of-health-technology-assessments-for-digital-therapeutics-in-germany-the-united-kingdom-and-france/ 2025-02-04T12:27:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-18.webp https://www.openhealthgroup.com/insights/a-us-survey-across-seven-early-stage-cancers-assessing-the-humanistic-burden-of-recurrence-on-patients-and-caregivers/ 2025-04-01T13:31:19+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-26.webp https://www.openhealthgroup.com/insights/what-next-for-the-science-of-patient-preference/ 2025-04-01T13:37:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-27.webp https://www.openhealthgroup.com/insights/can-we-trust-published-evidence-on-point-of-care-tests-for-cholesterol-a-rapid-review/ 2025-04-01T14:01:26+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-28.webp https://www.openhealthgroup.com/insights/leveraging-social-media-data-to-study-disease-and-treatment-characteristics-of-hodgkins-lymphoma-using-natural-language-processing-methods/ 2025-04-01T14:07:42+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-29.webp https://www.openhealthgroup.com/insights/posaconazole-effectiveness-in-rare-invasive-fungal-infections-a-systematic-literature-review/ 2025-04-01T14:26:43+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-30.webp https://www.openhealthgroup.com/insights/content-validation-of-the-qol-b-rd-and-promis-f-sf-7a-to-measure-respiratory-and-fatigue-symptoms-of-mac-lung-disease/ 2025-04-01T14:36:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-31.webp https://www.openhealthgroup.com/insights/impact-of-recurrence-on-employment-finances-and-productivity-for-early-stage-cancer-patients-and-caregivers-us-survey/ 2025-04-01T14:46:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-32.webp https://www.openhealthgroup.com/insights/symptoms-across-the-phases-of-the-migraine-cycle-from-the-patients-perspective-results-of-the-micoas-qualitative-study/ 2025-04-01T14:52:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-33.webp https://www.openhealthgroup.com/insights/potential-barriers-to-implementation-of-next-generation-sequencing-in-cancer-management-a-u-s-physician-based-survey/ 2025-04-09T13:34:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics.webp https://www.openhealthgroup.com/insights/psychometric-validation-of-the-cystic-fibrosis-impact-questionnaire-cf-iq-a-patient-reported-outcome-assessing-impacts-of-cystic-fibrosis/ 2025-04-09T13:45:18+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-1-1.webp https://www.openhealthgroup.com/insights/a-cross-sectional-survey-of-physicians-to-understand-biomarker-testing-and-treatment-patterns-in-patients-with-prostate-cancer-in-the-usa-eu5-japan-and-china/ 2025-04-09T13:50:29+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-3.webp https://www.openhealthgroup.com/insights/knowledge-attitudes-and-perceptions-towards-pneumococcal-vaccines-among-adults-in-the-united-states/ 2025-04-09T13:59:29+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-2.webp https://www.openhealthgroup.com/insights/real-world-outcomes-in-patients-with-melanoma-brain-metastasis-a-us-multisite-retrospective-chart-review-study-of-systemic-treatments/ 2025-04-09T14:06:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-4.webp https://www.openhealthgroup.com/insights/post-hoc-assessment-of-cognitive-efficacy-in-alzheimers-disease-using-a-latent-growth-mixture-model-in-ambar-a-phase-2b-randomized-controlled-trial/ 2025-04-09T14:24:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-5.webp https://www.openhealthgroup.com/insights/a-2021-clinician-survey-of-treatment-approaches-for-people-with-new-diagnoses-of-relapsing-remitting-multiple-sclerosis-in-the-united-kingdom/ 2025-04-11T12:05:29+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-11-1.webp https://www.openhealthgroup.com/insights/current-practices-for-the-management-of-advanced-high-grade-epithelial-ovarian-cancer-in-the-uk/ 2025-04-11T12:13:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-12.webp https://www.openhealthgroup.com/insights/effectiveness-and-safety-of-treatments-for-early-stage-merkel-cell-carcinoma-a-systematic-review-and-meta-analysis-of-randomized-and-non-randomized-studies/ 2025-04-11T12:20:34+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-13.webp https://www.openhealthgroup.com/insights/enhancing-patient-engagement-in-hta-using-consensus-research-to-overcome-pico-scoping-challenges-under-the-eu-htar/ 2025-06-10T12:38:31+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-36.webp https://www.openhealthgroup.com/insights/real-world-treatment-patterns-and-clinical-outcomes-in-patients-with-advanced-or-recurrent-endometrial-cancer-re-challenged-with-platinum-based-chemotherapy-in-europe/ 2025-09-04T13:37:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-36-1.webp https://www.openhealthgroup.com/insights/treatment-patterns-and-burden-of-uncomplicated-urinary-tract-infection-in-england-a-retrospective-cohort-study/ 2025-09-04T13:43:19+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-37.webp https://www.openhealthgroup.com/insights/a-cost-effectiveness-analysis-of-abemaciclib-in-combination-with-adjuvant-endocrine-therapy-for-hr-her2-node-positive-high-risk-early-breast-cancer/ 2025-09-11T12:12:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/B.Cancer.webp https://www.openhealthgroup.com/insights/survey-on-the-initiation-of-aripiprazole-once-monthly-via-a-two-injection-start-in-adult-patients-with-schizophrenia-experience-of-european-healthcare-professionals/ 2025-09-11T12:23:18+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Brain-1.webp https://www.openhealthgroup.com/insights/assessment-of-functional-recovery-in-patients-with-schizophrenia-with-a-focus-on-early-phase-disease-results-from-a-delphi-consensus-and-narrative-review/ 2025-09-11T12:28:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-42.webp https://www.openhealthgroup.com/insights/direct-economic-burden-of-post-cancer-treatment-pain-among-cancer-survivors-in-the-united-states-a-population-based-retrospective-longitudinal-study/ 2025-09-11T12:38:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-43.webp https://www.openhealthgroup.com/insights/determining-health-care-cost-drivers-in-older-hodgkin-lymphoma-survivors-using-interpretable-machine-learning-methods/ 2025-09-11T12:43:32+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-44.webp https://www.openhealthgroup.com/insights/psychometric-validation-of-the-eortc-qlq-oes18-in-patients-with-advanced-or-metastatic-esophageal-squamous-cell-carcinoma/ 2025-09-11T13:01:25+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/esophageal-squamous-cell-carcinoma.webp https://www.openhealthgroup.com/insights/healthcare-utilization-and-costs-in-adults-with-type-2-diabetes-treated-with-first-or-second-generation-basal-insulins-in-england/ 2025-09-11T13:08:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/type-2-diabetes.webp https://www.openhealthgroup.com/insights/real-world-management-resource-use-patient-reported-outcomes-and-adherence-in-patients-receiving-direct-oral-anticoagulants-for-first-stroke-attributed-to-non-valvular-atrial-fibrillation-in-seconda/ 2025-09-11T13:17:45+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart-1.webp https://www.openhealthgroup.com/insights/engaging-underserved-populations-in-health-preference-research-challenges-and-strategies/ 2025-09-11T13:39:42+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/health-preference-research.webp https://www.openhealthgroup.com/insights/clinical-profile-of-patients-with-comorbid-ibd-and-ms-and-associated-service-impact-in-englands-secondary-care-setting-a-retrospective-cohort-study/ 2025-10-20T14:07:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-50-1.webp https://www.openhealthgroup.com/insights/indirect-comparison-of-epcoritamab-vs-chemoimmunotherapy-mosunetuzumab-or-odronextamab-in-follicular-lymphoma/ 2025-10-20T14:13:35+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/follicular-lymphoma.webp https://www.openhealthgroup.com/insights/economic-burden-of-postsurgical-chronic-hypoparathyroidism-a-us-medicare-claims-retrospective-analysis/ 2025-10-20T15:07:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Medicare.webp https://www.openhealthgroup.com/insights/risk-of-cardiovascular-events-infections-and-renal-complications-in-postsurgical-chronic-hypoparathyroidism-a-us-medicare-claims-retrospective-analysis/ 2025-10-20T15:10:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart1.png https://www.openhealthgroup.com/insights/cost-effectiveness-of-mavacamten-for-the-treatment-of-patients-with-symptomatic-obstructive-hypertrophic-cardiomyopathy-using-a-french-healthcare-perspective/ 2025-10-20T15:15:40+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cardiomyopathy.webp https://www.openhealthgroup.com/insights/initiating-hpv-vaccination-at-age-9-strategies-for-success-from-five-us-health-systems/ 2025-10-20T15:21:40+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HPV-1.webp https://www.openhealthgroup.com/insights/long-term-mortality-and-morbidity-impact-on-patients-with-pulmonary-arterial-hypertension-pah-if-access-to-sotatercept-is-delayed-a-simulation-model/ 2025-10-20T15:27:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pulmonary-Arterial-Hypertension.webp https://www.openhealthgroup.com/insights/enfortumab-vedotin-plus-pembrolizumab-versus-chemotherapy-in-patients-with-previously-untreated-locally-advanced-or-metastatic-urothelial-cancer-ev-302-patient-reported-outcomes-from-an-open-label/ 2025-10-20T15:33:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-51.webp https://www.openhealthgroup.com/insights/treatment-discontinuation-and-switching-of-antipsychotics-among-adult-patients-with-schizophrenia/ 2025-12-01T15:45:35+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Schizophrenia.jpg https://www.openhealthgroup.com/insights/physician-perceptions-knowledge-and-implementation-of-lipid-lowering-guidelines-in-the-usa/ 2025-12-01T16:14:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lipids.webp https://www.openhealthgroup.com/insights/q-twist-analysis-of-first-line-nivolumab-plus-chemotherapy-versus-chemotherapy-in-patients-with-advanced-gastric-cancer-gastroesophageal-junction-cancer-or-esophageal-adenocarcinoma-from-checkmate-6/ 2026-01-09T12:31:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-50-1.webp https://www.openhealthgroup.com/insights/type-of-pre-existing-chronic-conditions-and-their-associations-with-merkel-cell-carcinoma-mcc-treatment-prediction-and-interpretation-using-machine-learning-methods/ 2026-01-09T12:39:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Renal-cell-carcinoma_2023-09-22-132145_mkum.png https://www.openhealthgroup.com/insights/cardiovascular-safety-outcomes-of-chronic-lymphocytic-leukemia-treatments-a-systematic-and-targeted-literature-review/ 2026-01-28T21:23:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-1.jpeg https://www.openhealthgroup.com/insights/a-multi-country-time-and-motion-study-to-describe-the-experience-and-burden-associated-with-the-treatment-of-fabry-disease-with-enzyme-replacement-therapy-with-agalsidase-alfa-and-agalsidase-beta/ 2026-01-28T21:32:37+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Radiotherapy.jpg https://www.openhealthgroup.com/insights/a-multi-country-time-and-motion-study-to-describe-the-experience-and-burden-associated-with-the-treatment-of-fabry-disease-with-enzyme-replacement-therapy-with-agalsidase-alfa-and-agalsidase-beta-2/ 2026-01-28T21:38:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan_2023-08-24-123234_geqk.png https://www.openhealthgroup.com/insights/challenges-in-the-treatment-of-hepatorenal-syndrome-acute-kidney-injury-a-us-chart-review-of-treatment-patterns-and-survival-outcomes/ 2026-03-06T09:06:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney_2023-10-02-132553_vlji.png https://www.openhealthgroup.com/insights/a-systematic-literature-review-of-preference-studies-in-migraine-treatments/ 2026-03-06T09:09:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/migraine1.png https://www.openhealthgroup.com/insights/content-validity-of-the-hemophilia-device-handling-and-preference-assessment-questionnaire-a-cognitive-debrief-study-in-patients-with-hemophilia/ 2026-03-06T09:14:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Patient4_bc9e4c42e52fd22ff41eda620350ec20.jpg https://www.openhealthgroup.com/insights/empowering-heart-failure-patients-the-role-importance-and-considerations-of-active-patient-engagement-in-improving-delivery-of-guideline-directed-medical-therapy/ 2026-03-06T09:24:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart2.png https://www.openhealthgroup.com/insights/initiating-human-papillomavirus-vaccination-at-age-9-strategies-for-success-from-5-us-health-systems/ 2026-03-06T09:31:34+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/vaccine_2023-10-18-144513_cxll.png https://www.openhealthgroup.com/insights/incremental-healthcare-resource-utilization-and-costs-among-people-living-with-hiv-with-and-without-cardiovascular-disease-hypertension-and-type-2-diabetes-mellitus-in-the-united-states/ 2026-03-06T09:37:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV_2022-08-12-141828_rtop.png https://www.openhealthgroup.com/insights/venetoclax-in-combination-with-obinutuzumab-in-previously-untreated-fit-patients-with-chronic-lymphocytic-leukemia-a-canadian-cost-utility-analysis/ 2026-03-06T10:14:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Leukemia-e1583505961954.jpeg https://www.openhealthgroup.com/insights/postimmunotherapy-and-vascular-endothelial-growth-factor-inhibitor-landscape-in-advanced-renal-cell-carcinoma-treatment-patterns-costs-and-outcomes/ 2026-03-06T10:22:38+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Renal-cell-carcinoma.png https://www.openhealthgroup.com/insights/physician-and-professional-caregiver-perspectives-on-meaningful-change-in-agitation-behaviors-in-alzheimers-dementia-insights-from-qualitative-interviews/ 2026-03-06T10:26:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain-scan_2022-12-19-104514_fjyt.png https://www.openhealthgroup.com/insights/challenges-in-the-treatment-of-hepatorenal-syndrome-acute-kidney-injury/ 2026-05-04T12:09:23+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/kidney.png https://www.openhealthgroup.com/insights/psychometric-validation-of-the-promis-fatigue-short-form-7a-in-adults-with-newly-diagnosed-or-recurrent-mycobacterium-avium-complex-mac-lung-disease-the-arise-and-encore-studies/ 2026-05-04T12:14:32+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lungs.jpg https://www.openhealthgroup.com/insights/incremental-healthcare-resource-utilization-and-costs-among-people-living-with-hiv-with-and-without-chronic-kidney-disease-in-the-united-states/ 2026-05-04T12:17:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HIV.png https://www.openhealthgroup.com/insights/net-health-benefit-of-mavacamten-for-the-treatment-of-chinese-patients-with-obstructive-hypertrophic-cardiomyopathy-a-model-based-economic-evaluation/ 2026-05-04T12:21:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/heart1.png https://www.openhealthgroup.com/insights/minimal-criteria-to-screen-for-wilson-disease-a-delphi-consensus-in-the-united-states/ 2026-05-04T12:46:43+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pediatric-neurology_2023-07-11-133343_piin.png https://www.openhealthgroup.com/insights/indirect-comparison-of-epcoritamab-versus-axicabtagene-ciloleucel-in-chimeric-antigen-receptor-t-cell-eligible-and-naive-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma/ 2026-05-04T12:51:23+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/lymphoma.png https://www.openhealthgroup.com/insights/exploring-the-relationship-between-obesity-weight-loss-and-health-related-quality-of-life-an-updated-systematic-review-of-reviews/ 2026-05-04T12:56:32+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-doctor_2022-12-19-105023_szla.png https://www.openhealthgroup.com/insights/a-cost-effectiveness-analysis-of-deucravacitinib-vs-apremilast-in-moderate-to-severe-psoriasis-patients-in-japan/ 2026-05-04T13:19:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/psoriasis_2023-08-24-122458_tlta.png https://www.openhealthgroup.com/insights/understanding-the-use-of-atypical-antipsychotic-treatment-for-major-depressive-disorder-an-international-cross-sectional-survey-of-health-care-providers/ 2026-05-21T10:47:38+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/brain_2023-12-19-134646_hdsf.png https://www.openhealthgroup.com/insights/accelerating-diagnosis-in-rare-disease/ 2026-09-15T13:31:45+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Gavin-Jones.png https://www.openhealthgroup.com/insights/disruptors-enablers-and-real-world-evidence-solutions-at-17th-annual-eyeforpharma-conference-barcelona/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/parc-guell-barcelona.jpg https://www.openhealthgroup.com/insights/being-in-the-shoes-of-a-launch-lead-lessons-from-the-front-line/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/launch-lead-thumb.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infographic-v8-scaled.jpg https://www.openhealthgroup.com/insights/medaffairs-leaders-forum-26-28-february-london-how-patient-centred-outcomes-can-enhance-your-evidence-strategy/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PCOs-Angela_MALF-slide-centered-resized.jpeg https://www.openhealthgroup.com/wp-content/uploads/2026/09/PCOs-Angela_MALF-slide.jpg https://www.openhealthgroup.com/insights/celebrating-world-haemophilia-day/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ATTE-1200x800-1.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/haemophilia-comic-1@2x-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/haemophilia-comic-2@2x-scaled.jpg https://www.openhealthgroup.com/insights/the-central-role-of-the-hospital-pharmacist-lessons-from-eahp-2019/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/barcelona-3226639_1920.jpeg https://www.openhealthgroup.com/insights/the-latest-in-ibd-from-the-european-crohns-and-colitis-organisation-ecco-2019-congress/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/HEADER.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/333.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/IMG_1612-scaled.jpg https://www.openhealthgroup.com/insights/the-critical-role-of-medical-affairs-getting-fit-for-the-future/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MAPS-background-image.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Peloton-bullets@2x.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Word-Art-9-5.png https://www.openhealthgroup.com/insights/eyeforpharma-conference/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/arvin-chingcuangco-1337417-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/pathway-to-launch-excellence/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Pathway-to-Launch-Excellence.jpg https://www.openhealthgroup.com/insights/gaining-market-access-for-tumour-agnostic-drugs-is-a-fair-price-the-only-challenge/ 2026-09-15T13:31:46+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cancer-cells-shutterstock_759448609-purchased.jpg https://www.openhealthgroup.com/insights/are-communication-research-materials-truly-patient-friendly/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/robert-koorenny-433377-unsplash-1.jpg https://www.openhealthgroup.com/insights/co-creating-solutions-for-quality-patient-engagement/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-engagement-picture.jpg https://www.openhealthgroup.com/insights/highlights-from-the-annual-meeting-of-the-international-society-for-medical-publication-professionals-ismpp/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/the-climate-reality-project-349094-unsplash_190501_163448-scaled.jpg https://www.openhealthgroup.com/insights/on-the-pursuit-of-excellence-in-market-research/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Neil-Ed.jpg https://www.openhealthgroup.com/insights/open-health-committed-to-patient-outcomes-in-rare-oncology/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rare-oncology.png https://www.openhealthgroup.com/insights/looking-back-at-asco-2019/ 2026-09-15T13:31:47+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/KUUV9511.jpg https://www.openhealthgroup.com/insights/is-the-future-multi-channel-or-multi-disciplinary/ 2026-09-15T13:31:48+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/multichannel.jpg https://www.openhealthgroup.com/insights/key-takeaways-and-trends-from-the-annual-meeting-of-the-american-academy-of-neurology-defining-an-era-of-newrology/ 2026-09-15T13:31:48+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hal-gatewood-405338-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/the-ai-revolution-how-artificial-intelligence-is-transforming-the-healthcare-sector/ 2026-09-15T13:31:48+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cyborg-2765349_960_720-royalty-free-no-usage-restrictions.jpg https://www.openhealthgroup.com/insights/precision-medicine-with-precision-management-and-precision-pricing-ensuring-affordability-in-the-cell-and-gene-therapy-era/ 2026-09-15T13:31:48+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/cells-1872666_1920.jpg https://www.openhealthgroup.com/insights/what-does-being-patient-centric-really-truly-mean/ 2026-09-15T13:31:48+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/support.jpg https://www.openhealthgroup.com/insights/generating-data-on-long-term-outcomes-to-demonstrate-the-value-of-gene-and-other-advanced-therapies-2/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PCN-1.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ILLUSTRATION-FOR-RARE-DISEASE-scaled.png https://www.openhealthgroup.com/insights/are-you-using-patient-reported-outcomes-pros-in-your-oncology-trials-if-not-why-not/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PRO-article-image-purchased.jpg https://www.openhealthgroup.com/insights/maps-blog-series-part-one-unlocking-the-potential-of-medical-affairs-part-one/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/maps.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-insights-and-market-research-in-pharma/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/open-health-reflections-on-the-world-orphan-drug-congress-in-barcelona/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/atazia.jpg https://www.openhealthgroup.com/insights/patient-journey-mapping-exploring-the-clinical-and-the-emotional-journey/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/louis-reed-pwcKF7L4-no-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-strategic-planning-in-pharma/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/open-health-mobilised-to-support-outcomes-with-gene-and-other-advanced-therapies/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_558228037.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-medical-and-scientific-writing/ 2026-09-15T13:31:49+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-learning-and-development/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/2.png https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-patient-centricity-in-pharma/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/the-essential-role-of-patient-reported-outcomes-in-real-world-evidence/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/PCO.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-patient-engagement-in-pharma/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/the-challenges-in-accessing-cannabis-based-medicines/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Medicinal-Cannabis-shutterstock_license-purchased.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-kol-maximisation-in-pharma/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/from-nice-to-have-to-must-have/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/patient-article.jpg https://www.openhealthgroup.com/insights/delivering-change-through-better-rare-disease-communications/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Delivering-change-through-better-rare-disease-communications-1200x675-Feature.jpg https://www.openhealthgroup.com/insights/equipping-your-medical-affairs-teams-with-solutions-to-navigate-the-healthcare-landscape/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_574043182-1.jpg https://www.openhealthgroup.com/insights/empowering-and-equipping-medical-affairs-teams-to-embrace-an-ever-expanding-remit/ 2026-09-15T13:31:50+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/chuttersnap-pgfWIStWIfs-unsplash-1-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Fig1.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Table.png https://www.openhealthgroup.com/insights/mapping-the-clinical-and-emotional-journey-to-better-understand-lived-experience/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Hospital_Ring.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/article.jpg https://www.openhealthgroup.com/insights/keeping-calm-and-carrying-on-covid-19-and-approaches-to-cme-cpd-during-a-viral-outbreak/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1621031059-1-1.jpg https://www.openhealthgroup.com/insights/my-dad-was-one-in-a-million-as-the-saying-goes-but-actually-he-was-one-in-300-million-of-patients-worldwide-with-rare-disease/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/rdd-logo-transparent111.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Emily-W-Father-2.png https://www.openhealthgroup.com/insights/improving-healthcare-communications-in-rare-disease-and-orphan-drugs/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_270524135-1-scaled.jpg https://www.openhealthgroup.com/insights/the-role-of-medical-affairs-in-positive-and-appropriate-engagement-with-patient-advocacy-groups/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/hush-naidoo-yo01Z-9HQAw-unsplash-1.jpg https://www.openhealthgroup.com/insights/open-healths-response-to-the-fdas-guidance-on-long-term-follow-up-post-gene-therapy/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1089540209.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-healthcare-communications-in-gene-therapy/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/spotlight-interview-15-minutes-on-digital-in-medical-communications/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Spotlight-Pic.jpg https://www.openhealthgroup.com/insights/what-is-adult-learning-theory-and-how-can-it-be-used-to-help-maximise-your-teams-potential/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/LD-Main-Cover-Image-Final.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-methodology.jpg https://www.openhealthgroup.com/insights/why-patient-engagement-really-matters/ 2026-09-15T13:31:51+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_662613667-scaled.jpg https://www.openhealthgroup.com/insights/european-congress-on-rare-diseases-ecrd-2020-in-60-seconds/ 2026-09-15T13:31:52+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/daniel-frank-wKbWAMlHgNo-unsplash-1-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-1.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-2.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-3.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-4.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-5.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/ecrd-6.jpg https://www.openhealthgroup.com/insights/covid-19-and-the-impact-on-treatment-pathways/ 2026-09-15T13:31:52+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-Pathways-image-lightened.png https://www.openhealthgroup.com/insights/eb-world-congress-building-on-momentum-and-strength-in-numbers-for-epidermolysis-bullosa/ 2026-09-15T13:31:52+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/EB-skin-congress-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/OPEN-Health-blog-rare-disease.png https://www.openhealthgroup.com/insights/global-regulators-discuss-observational-studies-of-real-world-data-for-covid-19-treatments/ 2026-09-15T13:31:52+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/louis-reed-pwcKF7L4-no-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/new-models-for-agency-pitching-my-top-takeaways-from-the-pm-society-event/ 2026-09-15T13:31:52+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/glenn-carstens-peters-RLw-UC03Gwc-unsplash-1.jpg https://www.openhealthgroup.com/insights/delivering-medical-communications-when-travel-is-restricted-solving-the-6-most-common-problems/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/virtual-meetings-article.jpg https://www.openhealthgroup.com/insights/open-conversations-on-demand-webinars/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Open-Conversations-Logo_600x400.png https://www.openhealthgroup.com/insights/the-rare-youth-revolution-has-begun/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RR.jpg https://www.openhealthgroup.com/insights/top-tips-from-five-years-of-account-management/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/christina-victoria-craft-ZHys6xN7sUE-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/to-pitch-or-not-to-pitch-tips-on-media-relations-during-covid-19/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/media-relations-scaled.jpg https://www.openhealthgroup.com/insights/three-steps-i-take-for-stress-free-successful-virtual-meetings-and-events/ 2026-09-15T13:31:53+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Virtual-medcomms.jpg https://www.openhealthgroup.com/insights/the-field-team-are-off-the-road-what-should-they-do-next/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/nick-morrison-FHnnjk1Yj7Y-unsplash_200319_084012.jpg https://www.openhealthgroup.com/insights/visualising-data-highlights-from-the-2020-european-meeting-of-ismpp/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Chat_Ring_190305_092922.jpg https://www.openhealthgroup.com/insights/open-health-medical-communications-deliver-over-250-virtual-activities-during-covid-19-a-new-path-forward/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2002-OH-IMAGES_VCO57.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infographic-Aug-2020-web-1200x420-1-scaled.png https://www.openhealthgroup.com/insights/open-health-brings-the-best-of-both-worlds-to-maps-emea-2020/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/BestofBothWorlds_Banner-scaled.jpg https://www.openhealthgroup.com/insights/nord-rare-diseases-breakthrough-summit/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Untitled-design-8-1.png https://www.openhealthgroup.com/insights/the-patient-as-priority-how-can-effective-internal-training-contribute-to-improving-patient-outcomes/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/LD-CONNECTING-THE-DOTS-FINAL_VCO3-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/fig-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/fig-2.png https://www.openhealthgroup.com/insights/responding-to-dynamic-shifts-in-value-communications/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Responding-to-dynamic-shifts-in-value-communications.jpg https://www.openhealthgroup.com/insights/fireside-chat-with-bobby-gaspar/ 2026-09-15T13:31:54+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/national-cancer-institute-gyGyIEeikSw-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/open-healths-virtual-reflections-on-the-world-orphan-drug-congress-us/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Patient_Ring.jpg https://www.openhealthgroup.com/insights/better-supporting-adolescents-living-with-rare-educational-audio-session/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rare-Disease_Ladder-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Adolescents-scaled.png https://www.openhealthgroup.com/insights/disruptive-listening-to-better-engage-patients-in-research-highlights-from-the-patients-as-partners-europe-virtual-conference/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patients-as-Partners.jpg https://www.openhealthgroup.com/insights/improving-patient-transitions-for-people-living-with-rare-key-learnings/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rare-Disease_Ladder-scaled.jpg https://www.openhealthgroup.com/insights/losing-control-of-life-transitions-in-rare-disease-3-reasons-to-give-this-a-listen/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rare-Disease_Ladder-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar-summary-illustration-scaled.png https://www.openhealthgroup.com/insights/improving-life-transitions-for-people-living-with-rare/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Rare-Disease_Ladder_Banner2-scaled.jpg https://www.openhealthgroup.com/insights/market-access-in-2021-and-beyond-reflections-on-virtual-ispor-europe-2020/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_140221888.jpg https://www.openhealthgroup.com/insights/open-health-publish-our-2020-rare-disease-yearbook-1/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Butterfly-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Yearbook-image.png https://www.openhealthgroup.com/insights/what-does-medical-affairs-look-like-in-2021/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/neonbrand-3BfDXcn9sqM-unsplash.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Annemarie_Clegg_1_50.jpg https://www.openhealthgroup.com/insights/what-do-healthcare-professionals-hcps-really-think-about-virtual-medical-education/ 2026-09-15T13:31:55+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2002-OH-IMAGES_VCO57.jpg https://www.openhealthgroup.com/insights/what-nords-rareinsights-30-year-comparative-analysis-means-to-us-and-our-clients/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/LD-CONNECTING-THE-DOTS-FINAL_VCO-scaled.jpg https://www.openhealthgroup.com/insights/whats-in-it-for-me-how-to-engage-motivate-and-support-staff-with-internal-training/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/LD-CONNECTING-THE-DOTS-FINAL_VCO3-scaled.jpg https://www.openhealthgroup.com/insights/bringing-data-to-life-thinking-about-the-so-what/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/firmbee-com-jrh5lAq-mIs-unsplash.jpg https://www.openhealthgroup.com/insights/collaborate-with-clients-to-create-excellent-content/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OHTeamwork.jpg https://www.openhealthgroup.com/insights/five-new-approaches-to-optimize-your-publication-steering-committees-in-a-virtual-world/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leon-Oalh2MojUuk-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/cutting-through-the-noise-reaching-your-audience-in-a-covid-19-world/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/is-anybody-out-there-reflections-on-social-listening/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/web-banner.png https://www.openhealthgroup.com/insights/motivate-staff-and-manage-their-training-with-learner-journeys/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/priscilla-du-preez-nF8xhLMmg0c-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/make-your-training-relevant-for-the-modern-msl/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/headway-5QgIuuBxKwM-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/how-to-pick-the-perfect-training-program-for-your-healthcare-professionals/ 2026-09-15T13:31:56+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/annie-spratt-hCb3lIB8L8E-unsplash-1-scaled.jpg https://www.openhealthgroup.com/insights/maximize-your-training-investments-with-learning-and-development-specialists/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/leon-6awfTPLGaCE-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/losing-control-of-life-transitions-and-how-to-measure-its-impact-to-drive-the-value-of-positive-change/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/open-health-answers-your-questions-on-virtual-meetings-events/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/john-mcconnell-answers-the-pharmaceutical-industrys-questions-on-the-future-impact-of-covid-19-on-the-healthcare-landscape/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/open-health-partners-with-the-life-science-access-academy-on-monthly-health-economy-insight-conversations/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Woman_Headphones_Image_RGB.jpg https://www.openhealthgroup.com/insights/socially-awkward-what-social-media-has-to-offer-pharma/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/web-banner.png https://www.openhealthgroup.com/insights/rare-thoughts-outcomes-navigating-pathways-to-better-outcomes-in-rare/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-RARE-Journey-images.VCO4_-scaled.jpg https://www.openhealthgroup.com/insights/optimising-patient-pathways-in-rare-disease-through-and-beyond-the-covid-19-pandemic/ 2026-09-15T13:31:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/solving-5-common-challenges-in-transitioning-medical-communications-content-to-digital-formats/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/create-inclusive-training-programs-for-diverse-staff-and-foster-workplace-belonging/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OHTeamwork_210702_081823.jpg https://www.openhealthgroup.com/insights/develop-team-competencies-with-real-world-learning-and-authentic-assessments/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/antenna-ohNCIiKVT1g-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/data-led-diagnosis-accelerators-in-rare-disease/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/navigating-pathways-to-better-outcomes-in-rare/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-RARE-Journey-images.VCO4_-scaled.jpg https://www.openhealthgroup.com/insights/learn-how-to-step-forward-analyze-your-learners-digital-needs-and-digital-literacy-to-help-create-better-training-programs/ 2026-09-15T13:31:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2104-Blog-image-1024x620-1.jpg https://www.openhealthgroup.com/insights/mining-for-hidden-gems-working-with-internal-teams-to-identify-content-for-social-media/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/web-banner.png https://www.openhealthgroup.com/insights/make-your-training-real-world-ready-and-promote-the-patient-voice/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/campaign-creators-e6n7uoEnYbA-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/mobilising-pathways-to-accommodate-new-transformative-treatments-using-cf-as-a-case-study/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/on-demand-thumb.jpg https://www.openhealthgroup.com/insights/simple-as-a-one-pager-social-media-strategy-made-easy/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/web-banner.png https://www.openhealthgroup.com/insights/podcasts-a-modern-weapon-in-your-arsenal-of-training-tactics/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/soundtrap-n30_i7mx62o-unsplash-scaled.jpg https://www.openhealthgroup.com/insights/promoting-interactivity-motivation-and-engagement-in-virtual-learning/ 2026-09-15T13:31:59+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OHTeamwork.jpg https://www.openhealthgroup.com/insights/scalpel-or-sledgehammer-targeting-hcps-on-social-media/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/web-banner.png https://www.openhealthgroup.com/insights/watch-again-open-health-evidence-access-virtual-summit-part-2/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-5_2023-11-02-110751_ztgu.png https://www.openhealthgroup.com/insights/watch-again-evidence-access-virtual-summit-part-1/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-6_2023-11-02-110822_qugk.png https://www.openhealthgroup.com/insights/cutting-edge-conversation-biotech-market-access/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-3_2023-11-02-110718_ahrb.png https://www.openhealthgroup.com/insights/a-new-era-for-gene-therapy-and-rare-diseases-findings-from-the-world-orphan-drug-congress-usa-2021/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/National-Harbor.png https://www.openhealthgroup.com/insights/5-top-tips-for-delivering-a-successful-hybrid-meeting/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2113-Digital-creative_1024wx620px_final3.jpg https://www.openhealthgroup.com/insights/generating-data-on-long-term-outcomes-to-demonstrate-the-value-of-gene-and-other-advanced-therapies/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2017-Gene-Therapy-Web_blog_1024x620.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/RR-image-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/RR-image-2.png https://www.openhealthgroup.com/insights/demonstrating-the-value-of-gene-therapy-in-rare-disease/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2017-Gene-Therapy-Web_blog_1024x620.jpg https://www.openhealthgroup.com/insights/accelerating-and-sustaining-the-life-of-an-advanced-therapy-through-rare-insight-2/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2017-Gene-Therapy-Web_blog_1024x620.jpg https://www.openhealthgroup.com/insights/digital-innovations-fabulous-or-a-fad-where-to-invest-in-digital-for-maximum-learning-benefit-when-implementing-your-training-program/ 2026-09-15T13:32:00+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2104-Blog-image-1024x620_210729_082843.jpg https://www.openhealthgroup.com/insights/forming-early-partnerships-to-understand-the-patient-pathway/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-RARE-Journey-images.VCO4_-scaled.jpg https://www.openhealthgroup.com/insights/how-should-the-rare-community-react-to-this-weeks-news-from-bluebird-bio/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2017-Gene-Therapy-Web_blog_1024x620.jpg https://www.openhealthgroup.com/insights/measuring-success-through-digital-innovation-how-to-gather-good-data-to-evaluate-your-training-program-and-track-the-impact-of-technological-enhancements/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2104-Blog-image-1024x6203-1.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Evaluation-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Evaluation-2.png https://www.openhealthgroup.com/insights/navigating-pathways-draft/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-RARE-Journey-images.VCO4_-scaled.jpg https://www.openhealthgroup.com/insights/metrics-matter-measuring-learning-impact-in-healthcare-training/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OHTeamwork_210702_081823.jpg https://www.openhealthgroup.com/insights/realizing-the-ambition-of-star-wars-medicine-widely-available-gene-therapies-that-deliver-outcomes/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2017-Gene-Therapy-Web_blog_1024x620.jpg https://www.openhealthgroup.com/insights/technology-driven-or-technology-enhanced-design-how-to-choose-the-right-digital-tools-for-your-training-programmes-and-avoid-digital-fatigue/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2104-Blog-image-1024x6203-1.jpg https://www.openhealthgroup.com/insights/why-prioritize-the-patient-voice-when-developing-your-training-program-and-how-can-digital-innovation-help/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2104-Blog-image-1024x6202-1.jpg https://www.openhealthgroup.com/insights/applying-ai-and-machine-learning-to-accelerate-rare-diagnosis/ 2026-09-15T13:32:01+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2201-Fierce-header-1024x620-1.jpg https://www.openhealthgroup.com/insights/emerging-approaches-for-patient-centered-pro-endpoints/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_HCP1-1.jpg https://www.openhealthgroup.com/insights/omnichannel-marketing-using-ai-to-personalize-messaging-for-optimal-results/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SCNB2201-Fierce-header-JT-1024x620-1.jpg https://www.openhealthgroup.com/insights/medical-affairs-center-stage-in-scientific-engagement-strategies/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MA_Image.jpg https://www.openhealthgroup.com/insights/key-elements-of-a-real-world-evidence-generation-plan/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/RWEv2.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_KeyElements_Infographic_1920x1080.jpg https://www.openhealthgroup.com/insights/new-initiatives-from-the-european-parliament-to-drive-innovation-in-digital-health/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/pexels-tara-winstead-8386440-scaled.jpg https://www.openhealthgroup.com/insights/metna-ra-a-cross-sectional-electronic-survey-to-validate-a-new-methotrexate-treatment-adherence-tool-in-rheumatoid-arthritis/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-HCP-Patient-Ring.jpg https://www.openhealthgroup.com/insights/informing-patient-and-caregiver-decisions-towards-gene-therapy/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar-thumbnail_Patient-3_2023-11-02-110649_oxgj.png https://www.openhealthgroup.com/insights/precision-medicine-placing-the-patient-at-the-center-of-the-healthcare-journey/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_361231613-scaled.jpg https://www.openhealthgroup.com/insights/strategizing-rare-disease-awareness-education-globally/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar-thumbnail_meeting2_2023-11-02-110544_jhhp.png https://www.openhealthgroup.com/insights/why-i-am-fortunate-to-still-be-learning-lessons-in-rare/ 2026-09-15T13:32:02+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Tin-soldiers-3.png https://www.openhealthgroup.com/insights/5-hot-topics-in-digital-health-our-thoughts-from-the-digital-health-world-congress-2022/ 2026-09-15T13:32:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-02-3.jpg https://www.openhealthgroup.com/insights/effectively-articulating-burden-for-future-health-technology-assessment/ 2026-09-15T13:32:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-4_2023-11-02-110511_ydxb.png https://www.openhealthgroup.com/insights/omnichannel-the-first-step-for-future-ready-medical-communications/ 2026-09-15T13:32:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Atoms-Close-05-1.jpg https://www.openhealthgroup.com/insights/how-digital-health-is-changing-the-relationship-between-patients-and-health-providers/ 2026-09-15T13:32:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-header.jpg https://www.openhealthgroup.com/insights/maps-2022-omnichannel-communications-are-a-popular-topic-for-medical-affairs-with-many-looking-to-the-experts-for-how-to-make-it-work/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ATOMS_CLOSE_UP_02-scaled.png https://www.openhealthgroup.com/insights/the-defining-moment-at-the-european-congress-on-rare-diseases-orphan-products-2022/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ECRD-visual.png https://www.openhealthgroup.com/insights/the-role-of-medical-affairs-in-market-access/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Untitled-design-15.png https://www.openhealthgroup.com/insights/the-importance-of-multidisciplinary-collaboration-for-omnichannel-customer-engagement/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-02-3.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infographic-min-scaled.png https://www.openhealthgroup.com/insights/reflections-on-the-maps-2022-emea-annual-meeting/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-04.jpg https://www.openhealthgroup.com/insights/unlock-possibilities-with-open-health-after-ispor-us-2022/ 2026-09-15T13:32:04+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Atoms-Wide-1.jpg https://www.openhealthgroup.com/insights/reflections-on-the-maps-2022-global-annual-meeting/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-05-1.jpg https://www.openhealthgroup.com/insights/unlock-possibilities-with-open-healths-heor-communications-specialists/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/photo-1554415707-6e8cfc93fe23_2022-07-01-083246_pids-scaled.jpeg https://www.openhealthgroup.com/insights/what-we-learned-post-covid/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/marek-levak-GNVxujZ_CxU-unsplash_2022-03-29-141946_vqpf.jpg https://www.openhealthgroup.com/insights/educating-medical-professionals-for-that-rare-encounter/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Mother_Nurse_Girl_Hospital_NO-LOGO@150ppi.jpg https://www.openhealthgroup.com/insights/3-pillars-of-effective-patient-community-pharma-collaboration/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/3-Pillars-of-Effective-Patient-CommunityPharma-Collaboration-1.png https://www.openhealthgroup.com/insights/harness-the-power-of-heor-writing/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Two-ladies-working-NO-LOGO.jpg https://www.openhealthgroup.com/insights/esmo-2022-advances-in-oncology/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ESMO_2022.png https://www.openhealthgroup.com/insights/cancer-inequity-what-is-the-care-gap/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/CancerInequity.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cancer-inequity-map_2.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cancer-Gap-Map.png https://www.openhealthgroup.com/insights/making-heor-more-accessible-to-patients-plain-language-summary/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1816235105-scaled.jpg https://www.openhealthgroup.com/insights/mens-health-understanding-the-challenges-to-achieving-improved-health-and-wellbeing/ 2026-09-15T13:32:05+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Mens-health-article-2023.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/OCSR2023-Mens-Health-figure_White-scaled.png https://www.openhealthgroup.com/insights/medical-affairs-xcellence-conference-looking-to-the-future/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MSL-Summit-blog-visual-4.png https://www.openhealthgroup.com/insights/making-heor-more-accessible-to-patients/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar-thumbnail_meeting1.png https://www.openhealthgroup.com/insights/innovation-in-cancer-diagnosis-and-treatment/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Cancer-innovation-blog.png https://www.openhealthgroup.com/insights/placing-the-patient-at-the-heart-of-medical-affairs/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Podcast-thumbnail.png https://www.openhealthgroup.com/insights/opuf-getting-personal/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-HCP-Patient-Ring.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Blog_pic-Edited.png https://www.openhealthgroup.com/insights/reflections-on-the-evolving-role-of-msls/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MSL-Summit-blog-visual-2.png https://www.openhealthgroup.com/insights/drive-discover-dive/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-04.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Drive-discover-dive_2023-04-28-101751_mndq.png https://www.openhealthgroup.com/insights/breaking-down-barriers-to-patient-first-approaches-panel-discussion-summary/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/News-header-ISMPP-Panel-Summary_2023-05-10-104553_qukt.png https://www.openhealthgroup.com/insights/heor-and-access-support-for-a-new-product-in-the-treatment/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/StudioID-Articles-Posts.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-search-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-idea-bulb-2-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-rosette-oh-pink.svg https://www.openhealthgroup.com/insights/a-thoughtful-approach-to-patient-inclusion-in-publications/ 2026-09-15T13:32:06+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Header-image-5.png https://www.openhealthgroup.com/insights/expanding-the-role-of-medical-affairs-a-focus-on-omnichannel-execution-artificial-intelligence-and-health-equality/ 2026-09-15T13:32:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Two-ladies-working-NO-LOGO.jpg https://www.openhealthgroup.com/insights/coming-soon-joint-clinical-health-technology-assessments/ 2026-09-15T13:32:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Man_Woman_Desk@150ppi_NO-LOGO-1.jpg https://www.openhealthgroup.com/insights/awareness-acceptability-will-drive-adoption-of-digital-health-technologies/ 2026-09-15T13:32:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-2023-02-24T133837.300.png https://www.openhealthgroup.com/insights/developing-patient-accessible-publication-extenders-key-stakeholder-perspectives/ 2026-09-15T13:32:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient_news-header.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/graphics-2023-05-19T102257.059.png https://www.openhealthgroup.com/insights/including-the-patient-voice-in-publication-planning-and-development/ 2026-09-15T13:32:07+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Header-image-2.png https://www.openhealthgroup.com/insights/novel-oncology-therapies-require-innovative-methods-in-oncology-modeling/ 2026-09-15T13:32:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ATOMS_CLOSE_UP_02-scaled.png https://www.openhealthgroup.com/insights/incorporating-the-patient-voice-in-publications-how-to-identify-representative-patients/ 2026-09-15T13:32:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Header-image-3.png https://www.openhealthgroup.com/insights/living-patient-centricity-through-our-open-approach/ 2026-09-15T13:32:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infinity-Loop_4K_CMYK-for-article_2023-04-18-151307_owgb-scaled.jpg https://www.openhealthgroup.com/insights/the-patient-journey-map-utilizing-insights-and-analysis-to-deliver-meaningful-support/ 2026-09-15T13:32:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Mother_Nurse_Girl_Hospital_NO-LOGO@150ppi.jpg https://www.openhealthgroup.com/insights/the-evolving-role-of-rwe-to-support-your-medical-strategy/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Podcast-thumbnail.png https://www.openhealthgroup.com/insights/unlocking-possibilities-a-journey-to-cross-functional-omnichannel-readiness/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/thumbnail-2_2023-04-27-092340_vftx.png https://www.openhealthgroup.com/insights/highlights-from-the-patient-centricity-and-engagement-conference/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-01-2.png https://www.openhealthgroup.com/insights/medical-affairs-unlocking-possibilities-for-a-modern-approach-to-scientific-engagement/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Four-People-Office@150ppi.jpg https://www.openhealthgroup.com/insights/increasing-awareness-for-young-onset-parkinsons-disease-through-open-healths-data-driven-approach/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Office-Group-Laptop-@150ppi_NO-LOGO.jpg https://www.openhealthgroup.com/insights/cross-sectional-survey-in-pediatric-pneumococcal-vaccines-cited-by-cdcs-advisory-committee-on-immunization-practices/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/New-Pubs-Posts.png https://www.openhealthgroup.com/insights/innovation-in-f2f-hcp-engagement-and-patient-centricity/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Atoms-Wide-4.jpg https://www.openhealthgroup.com/insights/industry-trends-driving-decision-making-in-medical-affairs-a-roundup-from-maps-2023-emea-annual-meeting-part-1/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Wide_2023-06-01-115754_himd.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Maps-Article-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Slide2.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Slide1_2023-06-02-111714_qkxp.png https://www.openhealthgroup.com/insights/optimize-your-field-medical-team-for-the-omnichannel-world/ 2026-09-15T13:32:09+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Wide-2.jpg https://www.openhealthgroup.com/insights/the-challenges-of-modeling-rare-diseases-and-making-the-best-use-of-limited-data-in-modeling-rare-diseases/ 2026-09-15T13:32:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Atoms-Close-03-1.jpg https://www.openhealthgroup.com/insights/treatment-patterns-and-clinical-outcomes-in-newly-diagnosed-multiple-myeloma/ 2026-09-15T13:32:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-02.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-search-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-idea-bulb-2-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-rosette-oh-pink.svg https://www.openhealthgroup.com/insights/the-evolution-of-genomic-medicine-for-rare-disease-in-the-uk/ 2026-09-15T13:32:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/News-header-Genomic-Medicine-for-Rare-Disease-articel_2023-05-10-102550_uskm.png https://www.openhealthgroup.com/insights/us-access-launch-strategy/ 2026-09-15T13:32:10+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-04.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-search-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-idea-bulb-2-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-rosette-oh-pink.svg https://www.openhealthgroup.com/insights/highlights-from-ismpp-eu-2024-artificial-intelligence-patient-engagement-and-measuring-success-in-publications/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infinity-Loop-Hero-Banner_3200x2000px-3-1.jpg https://www.openhealthgroup.com/insights/new-guideline-to-support-consistent-and-complete-reporting-of-consensus-methods-in-biomedical-research/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-02.jpg https://www.openhealthgroup.com/insights/delivering-patient-centric-publications/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Podcast-thumbnail.png https://www.openhealthgroup.com/insights/eu-hta-joint-clinical-assessments-navigating-potential-challenges-ahead-of-2025/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-5_2023-11-27-170345_pjpy.png https://www.openhealthgroup.com/insights/a-new-guideline-for-reporting-consensus-based-methods-aims-to-enhance-trust-in-global-health-research/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-01-1_2023-10-03-075644_wgko.jpg https://www.openhealthgroup.com/insights/introducing-an-omnichannel-approach-in-medical-affairs/ 2026-09-15T13:32:11+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Fur-Close-04.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Omni-Med-affaris-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Omni-Med-affaris-2.png https://www.openhealthgroup.com/insights/the-top-five-themes-of-the-ash-annual-meeting/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Infinity-Loop-Hero-Banner_3200x2000px-3-scaled.jpg https://www.openhealthgroup.com/insights/partnership-with-biopharma-company-to-critically-assess-current-approach-to-scientific-communications/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/StudioID-Articles-Posts.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-search-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-idea-bulb-2-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-rosette-oh-pink.svg https://www.openhealthgroup.com/insights/the-right-measurement-frameworks-matter-for-demonstrating-treatment-efficacy-in-clinical-trials-for-alzheimers-disease/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/StudioID-Articles-Posts.png https://www.openhealthgroup.com/insights/utilizing-audience-related-insights-to-support-omnichannel-strategy-in-medical-affairs/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Podcast-thumbnail-2_2024-02-26-123106_kgyk.png https://www.openhealthgroup.com/insights/eu-htar-and-the-draft-jca-implementing-act-what-is-it-and-what-are-the-implications-for-the-industry/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Man_Woman_Desk@150ppi-1_bc9e4c42e52fd22ff41eda620350ec20.jpg https://www.openhealthgroup.com/insights/unlocking-the-potential-of-a-medical-affairs-budget/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/thumbnail-2_2023-04-27-092340_vftx.png https://www.openhealthgroup.com/insights/addressing-uncertainty-within-eu-hta-regulation/ 2026-09-15T13:32:12+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Man-on-laptop-NO-LOGO@150ppi_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-beth-lesher-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Beth_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/building-bridges-to-accelerate-innovation-in-medical-affairs-highlights-of-the-maps-2024-americas-annual-meeting/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Image-05_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-dana-dena-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Dana_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-wenjie-zhang-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Wenjie_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-laura-mccormick-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Laura_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-eleanor-bush-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:13+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Eleanor_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-sophie-tsai-md-mba-mhs-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:14+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Sophie_TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-karen-king-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:14+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Karen-Kind-TB_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/from-pixels-to-patients-harnessing-artificial-intelligence-in-medical-storytelling/ 2026-09-15T13:32:14+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Podcast-thumbnail-2_2024-02-26-123106_kgyk_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-hannah-tivey-phd-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:14+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Trailblazer-HT_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/ai-storytelling-and-the-future-of-medical-publishing-highlights-from-ismpps-20th-annual-meeting/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Meeting-_man_with_mug_NO_LOGO@150ppi-_banner_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/strategic-leadership-medical-omnichannel-and-ai-in-medical-affairs-highlights-from-the-maps-emea-annual-meeting/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Four-People-Office-@150ppi_NO-LOGO_banner_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-jennifer-stephens-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Trailblazers-single-image-posts-2_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/innovation-in-oncology-clinical-trials-transforming-research-with-cutting-edge-clinical-trial-designs-and-technologies/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Oncology-areticle-image_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/meet-our-scientific-trailblazers/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Trailblazer-BG1_4096x2160_AW_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/insights/data-visualization-the-convergence-of-scientific-data-and-value-based-graphics/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Background-DataViz2-Smaller_bc9e4c42e52fd22ff41eda620350ec20.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/Multi-disciplinary-Approach_2024-04-10-191642_qbxo_2bdf43a6ebfbc2aa9b6defcd29a3ad93.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/Principles-of-Data-Visualization_2024-04-10-191645_ttka_a8c38bdb50a2fed053b01e25edd34cec.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/Approach-to-Data-Visualization_a8c38bdb50a2fed053b01e25edd34cec.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/Chart-types_2024-04-10-191643_kirj_a8c38bdb50a2fed053b01e25edd34cec.webp https://www.openhealthgroup.com/insights/shared-decision-making-in-healthcare/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Carer__Man_NO_LOGO@150ppi.webp https://www.openhealthgroup.com/insights/meet-emma-winter-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Trailblazers-single-image-posts-1.png https://www.openhealthgroup.com/insights/the-rise-of-artificial-intelligence-for-evidence-synthesis-and-analysis/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/shutterstock_1157717062-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/AI-Sell-deck-v4_JCS_TS.pptx-300x169-1.png https://www.openhealthgroup.com/insights/the-science-behind-patient-stories/ 2026-09-15T13:32:15+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Patient-and-doctor.png https://www.openhealthgroup.com/insights/unlock-real-time-scientific-insights-from-conferences/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Background-1-scaled.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/fusion-conference-AI-tool-170x300-1.png https://www.openhealthgroup.com/insights/a-review-of-the-2024-quantitative-evidence-synthesis-guidelines-key-updates-and-future-directions/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Two-ladies-working-NO-LOGO.jpg https://www.openhealthgroup.com/insights/meet-emanuele-arca-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Trailblazers-Emanuele.png https://www.openhealthgroup.com/insights/meet-craig-ornstein-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/1.jpg https://www.openhealthgroup.com/insights/esmo-2024-highlights/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Header-Image.jpg https://www.openhealthgroup.com/insights/a-humanized-ai-approach-to-congress-insights/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Podcast-thumbnail-2_2024-02-26-123106_kgyk.png https://www.openhealthgroup.com/insights/integrated-evidence-generation-planning-driving-successful-reimbursement-and-life-cycle-management/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Webinar_UP_thumbnail-6_2023-11-02-110822_qugk.png https://www.openhealthgroup.com/insights/evidence-generation-for-jcas-how-can-ai-boost-efficiency-and-maintain-quality/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Man_Woman_Desk@150ppi_NO-LOGO.webp https://www.openhealthgroup.com/insights/highlights-of-open-healths-posters-from-ispor-europe-2024/ 2026-09-15T13:32:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH-Atoms-Close-02_2022-11-22-192932_cgpk_bc9e4c42e52fd22ff41eda620350ec20.jpg https://www.openhealthgroup.com/insights/exploring-progress-and-innovation-in-heor-market-access-a-recap-of-2024-and-a-look-at-whats-ahead-in-2025/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/EA-Thought-Leadership-Social-1.jpg https://www.openhealthgroup.com/insights/ismpp-eu-2025-highlights-key-takeaways-from-open-health/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ISMPP-hero-v2.webp https://www.openhealthgroup.com/insights/celebrating-women-in-science-at-open-health/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Man_Woman_Desk@150ppi_NO-LOGO.webp https://www.openhealthgroup.com/insights/looking-ahead-the-science-of-patient-preference/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-science-of-patient-preference.webp https://www.openhealthgroup.com/insights/meet-eleanor-lucas-an-open-health-scientific-trailblazer/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Eleanor-Lucas-2.webp https://www.openhealthgroup.com/insights/maps-2025-highlights-from-the-integrated-medical-communications-masterclass/ 2026-09-15T13:32:17+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-science-of-patient-preference.webp https://www.openhealthgroup.com/insights/maps-emea-2025-highlights/ 2026-09-15T13:32:19+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-right-combination-BG5.jpg https://www.openhealthgroup.com/insights/ismpp-us-2025-highlights/ 2026-09-15T13:32:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-right-combination-BG4.jpg https://www.openhealthgroup.com/insights/ispor-webinar-ai-in-evidence-synthesis-are-the-robots-taking-over/ 2026-09-15T13:32:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/SLR-webinar-1.webp https://www.openhealthgroup.com/insights/open-to-change-driving-the-future-of-med-comms/ 2026-09-15T13:32:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-right-combination-BG6.jpg https://www.openhealthgroup.com/insights/ai-in-action-revolutionizing-scientific-congresses-from-concept-to-conclusion/ 2026-09-15T13:32:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/virtual-meetings-article.jpg https://www.openhealthgroup.com/insights/harnessing-ai-to-develop-an-slr-program/ 2026-09-15T13:32:20+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OHSLR.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-search-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-idea-bulb-2-oh-pink.svg https://www.openhealthgroup.com/wp-content/uploads/2026/09/icon-rosette-oh-pink.svg https://www.openhealthgroup.com/insights/meet-florentin-kohnemann-phd-llm-shaping-strategic-market-access-across-europe/ 2026-09-15T13:32:21+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Dr.-Florentin-Kohnemann-scaled.webp https://www.openhealthgroup.com/insights/highlights-from-esmo-2025/ 2026-09-15T13:32:21+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-right-combination-BG4.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bladder-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Prostate.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Renal.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Breast.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Lung.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Ovarian.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Technology.png https://www.openhealthgroup.com/insights/meet-bashni-reddy-senior-advisor-global-strategy-strategic-market-access/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Bashni-Reddy-1-scaled.webp https://www.openhealthgroup.com/insights/trends-and-future-directions-in-high-impact-medical-conference-exhibits/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-Header-images-705-by-353-pixels-2.webp https://www.openhealthgroup.com/insights/ai-at-esmo-2025-many-advances-much-promise/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-Header-images-705-by-353-pixels-13.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/RWE-WP-authors-6-scaled.webp https://www.openhealthgroup.com/insights/ispor-publication-features-open-health-authors-on-ai-in-heor/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-Header-images-705-by-353-pixels-16.webp https://www.openhealthgroup.com/wp-content/uploads/2026/09/RWE-WP-authors-5-e1766513500547-scaled.webp https://www.openhealthgroup.com/insights/translating-car-t-momentum-into-real-world-impact/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-Header-images-705-by-353-pixels-15.webp https://www.openhealthgroup.com/insights/evidence-generation-only-faster-how-ai-and-tokenized-data-are-accelerating-rwe-without-compromising-on-scientific-rigor/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Website-Header-images-705-by-353-pixels-17.png https://www.openhealthgroup.com/insights/ismpp-european-meeting-2026-highlights/ 2026-09-15T13:32:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/The-right-combination-BG4.jpg https://www.openhealthgroup.com/wp-content/uploads/2026/09/Email-graphics-20-1030x1030-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Email-graphics-21-1030x1030-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Email-graphics-22-1030x1030-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Email-graphics-23-1030x1030-1.png https://www.openhealthgroup.com/wp-content/uploads/2026/09/Email-graphics-24.png https://www.openhealthgroup.com/insights/economic-burden-trajectories-in-commercially-insured-us-infants-with-respiratory-syncytial-virus/ 2026-09-15T14:19:03+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Table-Economic-Burden-Respiratory-Syncytial-Virus-e1555590034730.png https://www.openhealthgroup.com/insights/value-of-hospital-antimicrobial-stewardship-programs-asps-a-systematic-review/ 2026-09-15T14:19:08+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Descriptive-statistics-for-health-state-utilities-in-AML.jpeg https://www.openhealthgroup.com/insights/medical-resource-utilization-and-costs-from-subsequent-metastasis-in-prostate-cancer-pc-patients-initially-diagnosed-with-locoregional-disease/ 2026-09-15T14:19:16+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/ProstateCancer.jpeg https://www.openhealthgroup.com/insights/value-of-information-analytical-methods-report-2-of-the-ispor-value-of-information-analysis-emerging-good-practices-task-force/ 2026-09-15T14:19:57+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/marek-levak-GNVxujZ_CxU-unsplash_2022-06-27-123658_kcsc.jpg https://www.openhealthgroup.com/insights/value-of-information-analysis-for-research-decisions-an-introduction-report-1-of-the-ispor-value-of-information-analysis-emerging-good-practices-task-force/ 2026-09-15T14:19:58+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/VOI-Analysis-100-e1583847113155.jpeg https://www.openhealthgroup.com/insights/navigating-the-nocebo-effect-through-patient-engagement-is-the-key-to-setting-patients-up-for-success/ 2026-09-18T09:56:41+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/OH_Patient4_Ring-scaled.jpg https://www.openhealthgroup.com/insights/embracing-the-patient-voice-within-publications/ 2026-09-18T10:06:22+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/Header-image-4.png https://www.openhealthgroup.com/insights/digital-therapeutics-landscape-in-europe/ 2026-09-18T10:14:43+00:00 https://www.openhealthgroup.com/wp-content/uploads/2026/09/MMA_Laptop_ret_rgb.jpg